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OPSOMMING 
Alhoewel spierweefsel merkwaardige regenerasie kapasiteit vertoon ten 
opsigte van besering, is hierdie proses stadig en word soms vergesel met die 
vorming van letselweefsel asook ‘n gevolglike afname in kontaktiele 
kapasiteit na afloop van regenerasie.  Behandelingsmoontlikhede is skaars 
en meesal ondersteunend van aard.  Hierdie proses sluit spierstamselle 
(satelietselle), wat uiteindelik die ontstaan van die regenerasie van spier tot 
gevolg het, in.  
Die kontroversiële veld van lae vlak laserterapie (Engels: Low level laser 
therapy (LLLT)) het merkwaardige aansprake in die fasilitering met verskeie 
sagteweefsel wondgenesing.  Nietemin, die meganisme(s) wat voordelige 
effekte induseer, word nog nie goed begryp nie.   
Ons het die effek van LLLT, deur gebruik te maak van ‘n 638 nm laser op 
kultuur in vitro satelietselle sowel in-vivo, ondersoek.  Deur gebruik te maak 
van verskeie tegnieke is onder meer die metaboliese, sowel die 
seinstransduksie weë en antioksidantstatus na laserbestraling, gemeet. 
In reaksie op die laserbestraling het satelietselle (in kultuur) ‘n toename in 
MTT waardes getoon (‘n maatstaf van die metaboliese aktiwiteit) en ‘n 
afname in die antioksidantstatus (gemeet deur van die ORAC toets).  
Addisioneel het laserbestraling ook uitdrukking en fosforilering van verskeie 
proteïene betrokke in seintransduksieweë beïnvloed, insluitend Akt, STAT-3).   
Na afloop van hierdie effekte op satelietselle na laserbestraling, is daar 
gebruik gemaak van ‘n kneusbeseringsrotmodel om hierdie effekte in vivo te 
ondersoek.   Geen betekenisvolle verskille in die aantal satelietselle na 
laserbestraling is opgemerk nie, maar veranderings is wel opgemerk in 
weefsel- en bloed-antioksidantstatus (gemeet deur van die ORAC toets 
gebruik te maak).   
Gedurende die verloop van die studie is van verskeie standaardtegnieke 
gebruik gemaak om die effekte van laserbestraling op beide satelietselle in 
vitro en in vivo te ondersoek.   
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Dit het duidelik na vore gekom dat daar wel gepaardgaande probleme met 
van hierdie tegnieke voorgekom het, en dat van hierdie tegnieke nie gepas is 
vir ondersoek in laserbestralingsstudies nie.  Nietemin, die resultate toon wel 
dat laserbehandeling satelietselgedrag induseer wat verdere studie in hierdie 
veld noodsaak.   
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ABSTRACT 
Although muscle tissue demonstrates a remarkable capacity for regeneration 
following injury, this process is slow and often accompanied by the formation 
of scar tissue and a subsequent decrease in contractile capacity following 
regeneration. Treatment options are few and mostly supportive in nature.  
This regeneration process involves muscle stem cells (satellite cells) which 
ultimately give rise to the regenerated muscle.  
 
The contentious field of low level laser therapy (LLLT) has made remarkable 
claims in facilitating wound healing in soft tissue injuries of various types. Yet, 
the mechanism(s) invoked in these beneficial effects are poorly understood.  
 
We have investigated the effects of LLLT using a 638 nm laser on satellite 
cells in culture and in-vivo.  Using an array of techniques we have measured, 
amongst other things, metabolic responses to laser irradiation, signaling 
pathways activated/altered and antioxidant status. 
 
In response to laser irradiation satellite cells in culture showed an increase in 
MTT values (a measure of metabolic activity) and a decrease in antioxidant 
status (measured using the ORAC assay).  In addition laser irradiation also 
altered the expression and phosphorylation state of several signaling 
pathways, including Akt and STAT-3. 
  
Following on from this the effects of laser irradiation on satellite cells in-vivo 
was assessed in a rat model of contusion injury.  No significant differences in 
satellite cell number was found following laser irradiation, changes were seen 
in tissue antioxidant status and blood antioxidant status (measured using the 
ORAC assay). 
 
In the course of this study several standard techniques were used to 
investigate the effects of laser irradiation on satellite cells both in-vitro and in-
vivo.  It has become apparent that several of these techniques have 
problems associated with them that possibly make them inappropriate for 
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further use in studies involving laser irradiation.  However the results indicate 
that laser therapy is induces satellite cell behavior and further study is 
warranted in this field. 
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1. Chapter 1 
Introduction 
1.1 Skeletal muscle 
“Muscle” is not merely a term used for a type of tissue, but can be regarded as an 
organ with the specific function of enabling a organism to be mobile, facilitate 
respiration and act as a hydrostatic pump (though, as will later become clear, the 
role of muscle is not exhausted by its contractile function).  Skeletal muscle is 
derived from the mesoderm layer of the developing embryo (Blau, Pavlath et al. 
1985) and is a complex tissue arranged with three-dimensional architecture. It is 
sometimes neglected that the muscle, when considered as an organ, 
demonstrates a great deal of heterogeneity in tissue constituents in that the 
“muscle” organ is interwoven with a network of connective tissue, vascular 
structures and nervous tissue (Hiatt, Regensteiner et al. 1996). 
Thou the focus of this thesis lay on skeletal muscle, a quick mention regarding the 
characteristics of other categories of muscles shall be made: Smooth muscle 
differs from skeletal muscle in both its histological appearance and contractile 
mechanism.  These muscle cells have their own isoforms of contractile proteins 
and are arranged in a dramatically different manner than in striated muscle. 
Smooth muscle is notably an involuntary muscle, undergoing contraction in 
response to mechanical stretching or various chemical signals. Cardiac muscle 
(also a type of striated muscle) differs from skeletal muscle in that it is not a 
voluntary muscle (Kreuzberg, Willecke et al. 2006). Also, where skeletal muscles 
are long, linearly arranged fibres, cardiac muscles occasionally “branches out” 
(Sommer and Scherer 1985). 
Furthermore, cardiac muscle cells are usually mono-nucleated and form 
intercalated discs through which the cardiomyocytes are interconnected. This 
connection is both mechanical (allowing the physical transmission of force) as well 
as chemical (facilitating the propagation of the action potential from stimulating 
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nerves across multiple cells) (Kreuzberg, Willecke et al. 2006). Finally, these cells 
are also metabolically geared towards oxidative phosphorylation and can be 
considered fatigue resistant (Ventura-Clapier, Garnier et al. 2004). 
1.1.1 Morphology of striated muscle 
Terminally differentiated skeletal muscle cells are multinucleated and elongated 
fibres (myofibers) (Light and Champion 1984; Morgan and Partridge 2003). Each 
myofibre is bordered by the endomysium which in turn are collectively bundled and 
surrounded by the perimysium. These bundles of myofibres ensheathed by the 
perimysium are collectively known as a muscle fascicle. The fascicles forming the 
muscle group are surrounded by another layer of connective tissue, the epimysium 
(Maganaris and Paul 2000) (see Figure 1.1). Muscle is anchored to bone or some 
other structure via tendons through which biomechanical force is applied (by the 
shortening of muscle) to produce locomotion (Huxley 1985; Zajac 1989).This 
“contractile” process is known as the cross-bridge cycle (Brenner 1986; Gordon, 
Homsher et al. 2000). It might be considered a bit misleading to use the word 
“contraction”, since we are only referring to the generation of force which does not 
necessarily accompany a shortening of muscle fibres, for example as seen in an 
isometric contraction. 
The most basic contractile functioning unit in a myofibre is known as the 
sarcomere (see Figure 1.2 for description). The largest known protein to occur 
naturally,  titin, connects the Z-disk (N-terminal) with the M-band (c-terminal) 
forming a continuous filament across half the sarcomere (Trinick 1994). It is also 
believed to play a major role in muscle elasticity (Soteriou, Gamage et al. 1993; 
Linke and Leake 2004). The titin expands across the sarcomere and interacts with 
various other proteins, notably, myosin and other components of the thick (myosin) 
filament (Rayment, Rypniewski et al. 1993).  
Myosin itself is a protein consisting of a heavy and light chain. The total protein 
structure can be divided in to a “head”, “neck” and “tail” domain (Korn 2000), were 
the “head” consist of the “motor” where the hydrolysis of ATP produces the power 
stroke (Yanagida, Arata et al. 1985) which propels actin across the myosin chain. 
3 
 
 
 
 
Figure 1.1 Macro-structural organization of a typical striated muscle as seen from 
a correctional view. 
 
 
Myosin itself is a protein consisting of a heavy and light chain. The total 
protein structure can be divided in to a “head”, “neck” and “tail” domain (Korn 
2000), were the “head” consist of the “motor” where the hydrolysis of ATP 
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produces the power stroke (Yanagida, Arata et al. 1985) which propels actin 
across the myosin chain.  The structure that forms between the actin and 
myosin is referred to as the cross-bridge.  As the cross bridges apply force 
on the thick (myosin heavy- and a myosin light chain) and thin (actin) filament 
of each sarcomere, they produce the “power stroke”. With each power stroke, 
the filaments slide past each other, giving rise to the “sliding filament” 
mechanism of muscle contraction. This sliding motion of the filaments 
effectively draws the Z–lines towards each other (shortening the I-band, as 
well as the H-zone, but not the A-band or the M-line).  
These fibres must be able to withstand immense tensile stress and be able to 
propagate contractile force uniformly. The propagation of this force from a 
sarcomere towards a tendon is deceptively complex and will not be dealt with 
– the interested reader is referred to (Grounds et al., 2005; Monti et al., 
1999). Figure 1.2 illustrates the arrangement of thin and thick filaments to 
emphasize the 3-dimentional plane in which force is generated. 
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Figure 1.2 Micro-structural organization of a typical striated muscle. Note the 3-
dimensional arrangement of the thick and thin filaments. For the sake of clarity  
some contractile proteins (notably, titin) have been omitted. 
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1.1.2 Muscle plasticity and heterogeneity 
Muscle specialization covers a wide verity of contractile parameters. Muscle 
contraction can be required to be sustained for prolonged periods (for 
example the stabilizer muscles of the back (Schilling, Arnold et al. 2005)), or 
recruited for production of a sudden burst of force (for example the muscles 
involved in jaw movement such as the masseter muscle (Horton, Brandon et 
al. 2001)).  A fine contrast in extreme forms of adaptation can be seen in 
muscles used in sound generation (Rome, Cook et al., 1999; Conley and 
Lindstedt 2002; Rome 2006) as opposed to some slow-twitch muscles of 
sloth (Barany 1967; Hoyle 1969). It is with these specific contractile demands 
that muscle manifests itself in various forms.  These manifestations are due 
to the isoform types of myosin (both heavy and light chain) expressed in the 
individual myofibres. 
1.1.2.1  Myosin heavy­/light chain isoforms 
Multiple myosin heavy chain (MHC) isoforms are known to exist, derived from 
gene duplication and variable splice patterns (Berg, Powell et al. 2001; 
Briggs and Schachat 2002; Desjardins, Burkman et al. 2002), each with a 
characteristic contractile capability. Muscles are also not static in their MHC 
isoform configuration and can adapt according to mechanical or metabolic 
demands, such as that imposed by contractile stress (Jansson, Esbjornsson 
et al. 1990; Hicks, Ohlendieck et al. 1997; Pedemonte, Sandri et al. 1999; 
Dahmane, Djordjevic et al. 2006). But the plasticity observed in muscle organ 
is not limited to variation in the MHC contractile apparatus.  
There also exist different isoforms for the myosin light chain (MLC) 
(Talmadge, Roy et al. 1993; Jostarndt-Fogen, Puntschart et al. 1998; Bicer 
and Reiser 2004) that is able to influence contractile velocity (Sweeney, 
Kushmerick et al. 1988).  The MLCs seem to regulate MgATPase kinetics of 
the myosin motor through its interaction with actin (Timson 2003). This 
regulatory role has also been observed in cardiac muscles (which, like 
skeletal cells, are also striated) through modulating contractile force (altering 
the cross-bridge kinetics) without interacting with the catalytic site 
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(Yamashita, Sugiura et al. 2003). These MLCs have also been categorized 
according to fast/slow twice and can be paired to a MHC either as “matched” 
or “mismatched” (Stephenson 2001). Despite the modifying role of MLC, 
MHC still seems to be the major role player in dictating contractile 
performance of a muscle group (Ohtsuki, Maruyama et al. 1986; Bottinelli, 
Canepari et al. 1996; Pette and Staron 2000). 
1.1.2.2  Muscle types and their identification 
The first distinction between fibre types was made by Ranvier as early as 
1873 when he distinguished between “red” and “white” muscles (Ranvier 
1873). Modern techniques used to identify and distinguish fibre types were 
developed by Sréter (Seidel 1967) and Seidel (Sreter 1969) based on the 
observation that “fast” (white) and “slow” (red) muscles have different alkaline 
and acidic sensitivity in terms of ATPase activity . This happened at the same 
time that a connection between ATPase activity and muscle contraction 
velocity (or muscle shortening time) was established (Barany 1967).  
The difference in ATPase activity is directly dependant on the MHC isoforms 
being express in that muscle fibre (Fry, Allemeier et al. 1994; Staron 1997). 
This allows the identification of MHC on the basis of the chain isoform's pH-
sensitive ATPase activity. Also, since each isoform has a  different molecular 
weight, the identification of fibre type by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) is also possible (Pette, 
Peuker et al. 1999). Because of the difference in dominant strategies of 
cellular ATP production (either oxidative or glycolytic), fibre types can also be 
distinguish on the bases of relative metabolic enzymes composition (Pette, 
Peuker et al. 1999).  
Other techniques include the use of immunohistochemistry with fibre type 
specific monoclonal antibodies (Havenith, Visser et al. 1990), RT-PCR 
(Lefaucheur, Milan et al. 2004) and an in-vitro motility assay (IVMA) (Kron 
and Spudich 1986; Lowey, Waller et al. 1993). It is worth noting though that 
not all the above mentioned techniques correlate with each other (Staron 
1997; Lefaucheur, Milan et al. 2004).  
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1.1.2.3 Other adaptive strategies 
A muscle cell of a set volume must allocate its space economically to 
maximize functional utility. It is indeed no coincidence that the myonuclei lay 
outside the myotubes. The major units between which a myotube must divide 
its limited space (as dictated by contractile demand) are mitochondria; the 
sarcolemma and the myofibrils (Josephson 1975; Schaeffer, Conley et al. 
1996). Consequently, hypertrophic fast twitch muscles, compromise with a 
low mitochondrial density in favour of more myotubes which in turn translate 
into a more powerful contractile potential. Cross-section area of a single fibre 
also correlates with the fibre type: oxidative fibres tend to be smaller when 
compared to glycolytic fibres which tend to be bigger (Tesch and Karlsson 
1985). Also muscles with an extremely fast twitching time (thus requiring a 
short calcium-clearing period) typically have a larger volume allocated 
towards their sarcoplasmic reticulum, resulting in weaker contractile force 
generation (Josephson 1975; Rome and Lindstedt 1998).  
Another aspect regarding muscle adaptation is the structural or “macro” 
changes of muscle fibres in the context of their contractile function. An 
increase in glycolytic fibres (associated with resistance training) decreases 
capillary density, where as endurance exercise leads to an increase in the 
degree of vascularisation and a shift towards oxidative fibres (Tesch, 
Thorsson et al. 1984). Muscle fibres also can augment their molecular 
“oxygen stores” by increasing the expression of myoglobin. Myoglobin is a 
153 peptide long protein, structurally related to haemoglobin (Wittenberg and 
Wittenberg 1990) and is much more abundant in oxidative (slow, fatigue 
resistant) muscles (Gayeski and Honig 1986; Gayeski and Honig 1988; 
Ordway and Garry 2004). Since the heart muscles relay heavily on oxidative 
respiration, dead or dying tissue will liberate myoglobin. This liberated 
myoglobin is used as a molecular marker to indicate muscle damage in 
patients that present in emergency rooms or trauma centres with chest pain 
or other early symptoms of heart disease (such as a myocardial infarction or 
heart failure) (Weber, Rau et al. 2005). 
In the context of the above, human skeletal muscle fibres are classified 
according to the following “hierarchy” of types:  
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   Type I→ Type IIa→ Type (IIx/d) → Type IIb.  
In this order, shortening velocity and maximum power-velocity decrease, 
whilst fatigue resistance increases (Bottinelli, Canepari et al. 1996). This 
muscle type also correlates with MHC composition (Fry, Allemeier et al. 
1994; Staron 1997). 
One last factor worth a quick mention might as much be a result of muscle 
adaptation as it could facilitate adaptation. Curiously, it is found that the 
dispersion of satellite cells between fast- and slow-twitch muscles appears to 
be asymmetric (Schmalbruch and Hellhammer 1977; Gibson and Schultz 
1982; Snow 1983). This seems to hold true even for the distribution of fast-
/slow twitch fibres in the same muscle groups (Gibson and Schultz 1982). 
The significance of this, as well as the possible factors governing the 
“privileged” allocation of satellite cells remains unclear.  
The observation that satellite cells seem to be more common around 
capillaries (Schmalbruch and Hellhammer 1977) and motor-neuron junctions 
(Wokke, Van den Oord et al. 1989) does hint at some as of yet unidentified 
influence of these structures. As mentioned previously, slow twitch muscle 
seem to be more vascularised (Tesch, Thorsson et al. 1984). This could 
possibly account for the increase in satellite cell density in slow twitch fibres.  
1.1.2.4 Hybrid fibres 
Because of this dynamic plasticity of muscle, the fibre type composition is 
often complex. The distribution of slow- and fast twitch fibres in a muscle is 
often described as a “salt-and-pepper” distribution as both fibre types can be 
present in the same muscle (Schiaffino and Reggiani 1996; Schilling, Arnold 
et al. 2005). This composite distribution of muscle fibre types in a single 
muscle organ seems to be the product of the functional specialization of the 
muscle (Otis, Roy et al. 2004). Muscles thus present a “graded” organization 
of fast-to-slow twitch muscle types, as required by the contractile demand of 
the muscle. 
One could imagine the evolutionary advantage of having a contractile 
apparatus capable of generating a powerful contraction force for a prolonged 
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period of time. Unfortunately, no such a “magic bullet” exists in the context of 
contractile utility. As previously mentioned, myofibres face a trade off in 
function: more myofibrils give rise to greater contractile capacity, but reduce 
volume for mitochondria, present a larger cross section for oxygen to defuse 
across and less space for capillaries – thus rendering the muscle susceptible 
to fatigue. Because of this limitation, muscle cells need to continuously adapt 
to new contractile challenges and this give rise to hybrid fibres: myotubes 
expressing more than one type of MHC. 
On the level of an individual muscle fibre, adaptation takes place in gradual 
steps. Were a pure fibre type is considered a muscle fibre that only express 
one single type of MHC, some muscle fibres co-express various fibre types 
simultaneously, giving rise to hybrid fibre types (Lutz, Weber et al. 1979; 
Bottinelli, Betto et al. 1994; Sant'ana Pereira, Wessels et al. 1995). The co-
existence of this multiple isoforms is also known to influence contractile 
velocity (Larsson and Moss 1993; Bottinelli, Betto et al. 1994).  
In the context of muscle plasticity, hybrid fibre types represent a bridge over 
the transitionary gap between one muscle phenotype and another (Pette, 
Peuker et al. 1999; Pette and Staron 2000). 
1.1.2.5 Factors inducing muscle adaptation 
As already discussed, each of the cells in a muscle adapts according to the 
contractile demands imposed on them (Holloszy and Booth 1976). In terms of 
resistance training muscle adaptation leads to an increase in muscle mass 
and a shift towards powerful contractile machinery (namely, type IIb fibres) 
(Schiaffino and Reggiani 1996; Bottinelli and Reggiani 2000; Fluck and 
Hoppeler 2003).  
In contrast, chronic low intensity contractile stimulation of the tibialis anterior 
muscle in rabbits results in a dramatic switch form fast twitch towards slow 
twitch with an accompanied increase capacity for oxidative respiration (Pette 
and Vrbova 1992). The same adaptations have been observed in rat striated 
muscle (both skeletal and cardiac muscle) by examine modification in 
oxidative enzymes and muscle contractile characteristics (Baldwin, Cooke et 
al. 1977).  
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There also exist other metabolic and functional mechanisms by which muscle 
adaptation can be induced. An early example of muscle plasticity was 
provided by Buller et al when he was able to demonstrate a swap of muscle 
phenotype from slow twitch to fast twitch after cross-innervation of the 
respective muscle groups (Buller, Eccles et al. 1960). This adaptation 
mimicked the previously mentioned role of motor unit size in relation to 
muscle fibre type (Bewick, Zammit et al. 1993).  
The role of muscle recruitment was expanded upon by studies on the decline 
in muscle recruitment following a decrease in muscle loading (Thomason, 
Herrick et al. 1987), induced spinal cord damage (Talmadge, Roy et al. 1995) 
or muscle denervation (Carraro, Dalla Libera et al. 1982) - all of which shown 
to induce a shift in the type of muscle contractile machinery (see also 
(Talmadge 2000) for review on these effects).  
These results are similar to other findings on the effects of muscle unloading 
where a shift from slow to fast MHC isoform was observed (Talmadge, Roy 
et al. 1996; Talmadge, Roy et al. 1999). This muscular response seems to be 
time dependant as the phenotypic change varies upon the duration of 
unloading. A human study demonstrated an increase in maximum contractile 
force after 17 days of bed rest (Widrick, Romatowski et al. 1997) and 
presented the same results when duplicated in a space flight model (Widrick, 
Knuth et al. 1999). Similar results were found with a rodent model (Baldwin 
1996).  However, with increased durations of unloading 6 weeks of bed rest 
(Larsson, Li et al. 1996) and 3 months of immobilization (D’Antona 2000) are 
associated with a decrease in contraction velocity. 
The effect of cancer cachexia on a mice model illustrated an interesting shift 
form type I MHC towards type IIb MHC (Diffee, Kalfas et al. 2002) over a 21 
day period following  the injection of cancer cells. Chronic heart failure has 
also been shown to shift skeletal muscle type towards a glycolytic type 
(Drexler, Riede et al. 1992; Wilson, Mancini et al. 1993), where as regular 
aerobic exercise (cycling) seems to increase oxidative capacity via increased 
mitochondrial density, which was strongly correlated to an increase in type I 
fibres (Hambrecht, Niebauer et al. 1995; Hambrecht, Fiehn et al. 1997).  
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Another factor influencing fibre type is age. Aged individuals (88 ± 3 years) 
show a remarkable shift towards the co-expression of type I and type IIa 
muscle types, indicating that ageing itself (or an associated “symptom” of 
aging) seems to induce a transformation of muscle fibre type to a hybrid form 
(Andersen 2003).  
Alcoholism, in the context of malnutrition also seems to specifically deplete 
type II fibres (Fernandez-Sola, Sacanella et al. 1995). Of interest to in vitro 
modelling, it appears that muscle cells in culture always differentiate into fast 
twitch phenotype (type II) (Rubinstein and Holtzer 1979). 
1.1.3 Muscle from another angle  
Intuitively, the first image that comes to mind in response to the word 
“muscle” would most probably be in line with some notion of mobility or 
another representative motion of contraction. It is not without reason that our 
contractile function impresses us so much, for it is in our ability to manipulate 
our environment that we express ourselves (for example an artist hand 
guiding his brush over a piece of canvas) or indulge in recreational activities 
(for example playing rugby). Besides functioning as a motility organ, muscle 
also plays an important role in blood glucose metabolism (Kahn, Rosen et al. 
1992; Wright, Geiger et al. 2004; van Loon and Goodpaster 2006). Another 
aspect of muscle function relates to its “expendability”- muscle tissue acts as 
a storehouse for amino acids (Lopes, Russell et al. 1982). 
An additional role of muscle cells in the maintenance of homeostasis involves 
the endocrine function of this organ. It is know that muscle cells produce a 
multitude of cytokines and other signalling molecules (Segal 1994; 
Bruunsgaard, Hartkopp et al. 1997; Ostrowski, Rohde et al. 1999; Ostrowski, 
Rohde et al. 2001; Febbraio and Pedersen 2002). Considering the 
contribution muscles tissue makes to total body mass (Proctor, O'Brien et al. 
1999), the endocrine function of muscle can be substantial. In the light of all 
this, it has recently been proposed that some cytokines and other peptide 
hormones produced and excreted by muscle cells be dubbed “myokines” 
(Pedersen and Febbraio 2005). 
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Interestingly though it has been shown that muscle cells can perform an 
endocrine function that is not related to their contractile function.  What’s 
more, this endocrine function was found to be fibre type specific (Plomgaard, 
Penkowa et al. 2005). This fibre type specificity was maintained even when 
different muscle groups (triceps, vastus and soleus) of the same fibre type 
were sampled. Fibre type specificity was also found in response to muscle 
exercise were glycolytic fibres express higher concentration of IL-15 (Nielsen, 
Mounier et al. 2007). 
The muscle organ also provides the body with information valuable to the 
maintenance of homeostasis. For instance, muscle activity might 
communicate signals not induced by nerve impulses that cause metabolic 
alterations in other tissue (Pedersen and Febbraio 2005). Indeed, muscle 
derived IL-6 alone seems capable of influencing metabolism on a systemic 
level (i.e. not only skeletal muscle adaptation) (Febbraio and Pedersen 
2002). 
1.1.4 In summary 
Some of the mechanisms by which muscles “gear” their morphological and 
biochemical machinery towards contractile efficiency have been mentioned. 
These modifications might include: altering the organelle architecture (not 
only number), manipulating contractile components, muscle motor unit size, 
modification in sensitivity towards signalling cascades (e.g. calcium 
sensitivity and the fibre type-specific distribution of adrenergic receptors), 
increased sarcoplasmic reticulum volume, recruitment of metabolic 
machinery, and even adapting on the macro structure by altering capillary 
density (Buller, Eccles et al. 1960; Barany 1967; Henriksson and Reitman 
1977; Spamer and Pette 1977; Holloszy 1982; Holloszy and Coyle 1984; 
Breitbart and Nadal-Ginard 1987; Martin, Murphree et al. 1989; Simoneau 
and Bouchard 1989; Froemming, Murray et al. 2000; Fluck and Hoppeler 
2003; Novotova, Pavlovicova et al. 2006). 
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Table 1.1 Some parameters by which human fibre types can be compared. 
Adapted and modified from (Wang, Hikida et al. 1993; Fitts and Widrick 1996). 
 
 
  Slow-oxidative 
(Type I) 
Fast-oxidative 
(Type IIa) 
Fast-glycolytic 
(Type IIb) 
Metabolic 
strategy 
oxidative 
phosphorylation
oxidative 
phosphorylation
glycolytic 
Glycogen 
content 
low intermediate high 
Relative rate of 
fatigue 
slow intermediate fast 
Myoglobin 
content 
high high low 
Relative 
mitochondria 
many many  few 
Capillary 
density 
dens dens spares 
Fiber diameter small intermediate large 
Contractile 
velocity 
slow fast fast 
Motor unite 
size 
small intermediate large 
Satellite cell 
density 
high not specified in 
literature low 
 
1.2 Muscle injury and repair 
1.2.1 Muscle damage 
Muscle tissue is susceptible to a vast array of injuries. Because of its 
functional nature, injuries inflicted through shear stress are one of the most 
common types of injury seen, resulting in muscle tears or tendon ruptures 
(Garrett 1996). This type of injury is also more common in muscles working 
across two joints as seen in the femoris, gastrocnemius and semitendinosus 
muscles (Garrett 1996). A less common injury is laceration, produced by a 
sharp object making a transitional cut through myotubes. These types of 
injuries are relatively difficult to treat and usually result in the formation of 
scar tissue (Menetrey, Kasemkijwattana et al. 1999). 
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The functional position of muscle unavoidably places this organ in a 
precarious position. For one thing, our limbs are used to manipulate our 
environment and thus more prone to accidental injury. Secondly, as muscles 
are often flanked to the bone on which force is applied (or adjacent to some 
other bone), they are liable to be “pinned” between the underlying bone and 
an external object exerting force on the muscle. This results in a unique type 
of injury, which also represents the injury model investigated in this thesis’s in 
vivo section, namely contusion injury.  
Contusion injuries are generally caused by a compressive force acting on 
muscle (typically seen in blunt force trauma) without penetration of underlying 
tissue (Crisco, Jokl et al. 1994). Contusion injuries are second only to strain 
injuries as the dominant cause of sports related injuries (Beiner and Jokl 
2001), and are, by nature, more prevalent in contact sports like judo, karate 
and rugby (Beiner and Jokl 2001).  Despite their relative larger size (than 
strain injuries), contusion injuries generally heal more rapidly than strain 
injuries (Thorsson, Lilja et al. 1997). However, complications can arise, 
including compartment syndrome (Mulder, Sakoman et al. 1991) and 
pyomyositis (Patel, Olenginski et al. 1997).  
Besides muscle loss by injury, muscle wasting often accompanies other 
disease or degenerating states,  including: cancer (Tisdale 1997); HIV 
infection (Engel 1977; Kotler, Tierney et al. 1989; Hellerstein, Kahn et al. 
1990); aging (Lexell, Taylor et al. 1988; Pahor and Kritchevsky 1998) and 
some neuro-degenerative diseases (Bordet, Lesbordes et al. 2001; Wang, Lu 
et al. 2002). Muscles are also susceptible to infections like pyomyositis 
(Patel, Olenginski et al. 1997), strains of salmonella (Collazos, Mayo et al. 
1999) and streptococci (Stevens 1999) as well as parasitic infestation 
(Beiting, Bliss et al. 2004) and damage induced by cytotoxins (Rucavado, 
Escalante et al. 2002). 
1.2.2 Primary and secondary Injury 
In contusion injury, the primary injury to muscle involves the physical and 
structural disruption of tissue as well as immediate necrotic cell death that is 
implicated in tissue disorganization (Hurme, Kalimo et al. 1991). Following 
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contusion injury (the primary insult), the physical and localized chemical 
alterations might ultimately lead to the secondary injury through cell death 
resulting from the adverse environmental shift taking place at and around the 
site on injury. Another key aspect of secondary damage relates to 
subsequent engagement of an inflammatory response and the involvement of 
immune cells. Artificially dissecting primary and secondary injury would do 
insult to the intricate physiological relationship between the two injuries. 
Instead, primary and secondary injury will be discussed consecutively as the 
occasion arises. 
1.2.2.1  Primary injury ­ tissue disruption and cell death 
Following contusion injury of a skeletal muscle there is inevitably some 
degree of bleeding and in some instances the formation of a hematoma.  
This is due to the high level of vascularisation seen in skeletal muscle 
(Levenberg, Rouwkema et al. 2005).  This process occurs reasonably early 
following injury (Hurme, Kalimo et al. 1991). It has been found that primary 
spinal afferent neurons release pro-inflammatory neuropeptides capable of 
increasing inflammatory oedema (Steinhoff, Vergnolle et al. 2000).  
This early occurrence following injury results in swelling, which expands as 
the initial inflammatory response proceeds. The increase in pressure as a 
result of the inflammation and possible hematoma, as well as the vascular 
disruption, might cause local hypoxic conditions, as well as an accumulation 
of cellular waste products. In turn, this might result in the induction of 
secondary injuries, as these adverse conditions increase the amount of 
secondary cell death. 
In addition to the localised bleeding and swelling, the compromise in the 
myofibre’s sarcolemma integrity seen following the contusion results in an 
influx of extracellular calcium into the damaged myofibre which leads to the 
disruption of ionic homeostasis within the injured fibres (Trump and 
Berezesky 1995; Belcastro, Shewchuk et al. 1998). At the same time, a host 
of proteolytic enzymes (proteases liberated from damaged cells, muscle 
fibres and discharged from leukocytes) begin to digest the macromolecular 
17 
 
contractile machinery into smaller units for further degradation (Frenette, St-
Pierre et al. 2002).  
By virtue of their continuous, elongated structure, muscle cells face a unique 
threat when damaged. A single rupture point can theoretically compromise 
an entire cell. To halt the advance of such a necrotic threat, myofibres often 
form condensing plates of cytoskeletal proteins called contraction bands 
(Ganote 1983; Hurme, Kalimo et al. 1991) preventing the spread of injury and 
the death of the entire fibre. In addition the surviving myotubes tend to 
contract (as a result of the increased calcium concentration) (Warren, Hayes 
et al. 1993), thus distancing the surviving tissue from the injury  zone. This 
effectively localizes the site of necrosis and preserves the integrity of the 
surviving myofibre, minimizing injury. 
1.2.2.2 Secondary injury 
Secondary damage occurs at, and surrounding the site of the primary injury.  
This secondary injury is caused by numerous factors including (but not 
limited to): the disruption of the vasculature and the ensuing ischaemia; ionic 
disequilibrium; infiltration and activation of the immune cells (see sections 
below for more detail) and enzymatic degradation (as a result of the release 
of proteases from the damaged myofibres) to name but a few (also see 
Figure 1.3).  
18 
 
 
 
 
Figure 1.3 A brief illustrative summary demonstrating the homeostatic relationship 
between primary and secondary injury. This diagram is by no means exhaustive and 
arbitrarily outlines only some events in muscle injury. 
1.2.3 The inflammatory response 
An inflammatory response is generally described in the context of three 
phased events namely “damage”, “repair” and “remodelling” (which tend to 
overlap both spatially and temporally – see Figure 1.4 for illustration of distinct 
phases). The immediate function can be described as “homeostatic damage 
control” followed by the mobilization of immune cells.  
The presence of these immune cells represents a prophylactic strategy of the 
body to remove potential invading pathogens. Some leukocytes (notably, 
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those of a phagocyte phenotype) are also responsible for clearing up cellular 
debris (Lescaudron, Peltekian et al. 1999) – an important event in wound 
repair. Furthermore, these cells also contribute to the remodelling stage in 
various ways (Massimino, Rapizzi et al. 1997; Merly, Lescaudron et al. 1999; 
Meszaros, Reichner et al. 2000; Cantini, Giurisato et al. 2002; Allenbach, 
Zufferey et al. 2006). The inflammatory response is a complex and tightly 
orchestrated event, which quite often causes more damage, seen as 
secondary damage, than the initial injury itself  (Nathan 2002). 
Ruptured and necrotic cells liberate intercellular proteins that act as 
chemotactic agents (Carp 1982). These chemotactic agents can cause and/or 
aggravate the inflammatory response (Scaffidi, Misteli et al. 2002; Lauber, 
Blumenthal et al. 2004). Within 24 hours, neutrophils, phagocytes and other 
inflammatory cells invade the injured area and start removing cellular debris 
and any blood clots formed due to the vascular disruption caused as a result 
of the contusion (Tidball 2005). The short lived, non-dividing neutrophils (Roitti 
and Rabson 2000) are the first sub population of white blood cells to arrive at 
the site of injury (Pizza, Koh et al. 2002) and have been found to increase in  
number at the site of damage as early as one hour after an injury (Fielding, 
Manfredi et al. 1993; Belcastro, Arthur et al. 1996).  
Connective tissue mast cells colonize the muscle tissue (Galli 1993) in 
relatively low numbers but are capable of releasing a host of molecules in 
response to cytokines released by surrounding tissue during an inflammatory 
response (thus IgE independent) (Galli 1993) that induces and facilitates the 
chemotaxis of neutrophils (Gaboury, Johnston et al. 1995; Kubes and 
Gaboury 1996). Neutrophils are also capable of releasing a host of 
inflammatory cytokines including interleukin-8 (IL-8), interleukin-1 (IL-1), 
tumour necrosis factor-alpha (TNF-α) and Interferon-alpha (IFN-α) (Fielding, 
Manfredi et al. 1993; Cassatella 1995; Moilanen and Vapaatalo 1995; Tidball 
1995; Cannon and St Pierre 1998; Suzuki, Totsuka et al. 1999; Barbero, 
Benelli et al. 2001) which subsequently also recruit macrophages to the site of 
injury (Tidball 1995; Cannon and St Pierre 1998). 
Although the exact context in which neutrophils might exacerbate muscle 
injury remains unclear, there is consensus that, at least occasionally, the 
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inflammatory response seems to cause more damage than the injury itself 
(Nathan 2002). In this regard, in particular, neutrophils appear to be the “black 
sheep” by allegedly being the major contributor in the exacerbation of 
secondary damage caused by the inflammatory response seen following injury 
(Tidball 1995; Tiidus 1998; Pizza, McLoughlin et al. 2001; Tidball 2005). 
Supporting this view, an increase in secondary damage coincides with peak 
neutrophil invasion (Brickson, Hollander et al. 2001; Schneider, Sannes et al. 
2002). Indeed, the “excessive nature” of neutrophil induced inflammation is 
well described in cystic fibrosis, where neutrophils tend to be more of a hinder 
than a help (Konstan, Byard et al. 1995) and where anti-inflammatory 
medication seems to decrease morbidity (Auerbach, Williams et al. 1985; 
Eigen, Rosenstein et al. 1995; Konstan, Byard et al. 1995). The direct 
mechanisms by which neutrophils cause secondary damage seem to be 
mostly mediated by an increase reactive species production   (Welbourn, 
Goldman et al. 1991; Brickson, Hollander et al. 2001; Brickson, Ji et al. 2003). 
However, the role of neutrophils in secondary muscle injury is contentious.  
Following injury sustained after exercise some results has shown no direct 
evidence for neutrophil induced secondary damage (Lowe, Warren et al. 
1995; Lapointe, Frenette et al. 2002). In contrast, blocking the respiratory 
burst in neutrophils prior to stretching of rabbit muscles reduced the 
occurrence of muscle damage (Brickson, Ji et al. 2003), thus implicating 
neutrophil involvement in the damage seen following injury. These results 
have been corroborated by another study using a mice knock-out model. In 
this study it was found that a reduction in neutrophils in muscle tissue resulted 
in significant lower levels of muscle injury (Pizza, Peterson et al. 2005). 
Other notable leukocytes involved with inflammation are the longer-lived 
macrophages.  Macrophages accumulate at the site of injury (where they also 
undergo cell division) (Honda, Kimura et al. 1990) and gradually decline in 
number as the healing process progresses (St Pierre and Tidball 1994). Three 
distinct populations of macrophages can be distinguished: ED1+ve which are 
found in circulation and appear early following injury and seem mostly 
responsible for clearing up debris (Honda, Kimura et al. 1990), ED2+ve are 
“resident” macrophages found in the muscle tissue, but appear only later (St 
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Pierre Schneider, Correia et al. 1999) and ED3+ve which are mostly confined 
to the lymphatic system (Dijkstra, Dopp et al. 1985; Roitti and Rabson 2000).  
ED3+ve and ED2+ve macrophages only appear later on after the initial 
inflammatory response (McLennan 1993). 
The invasion of tissue by macrophages coincides with the onset of the 
regeneration phase (Hopkinson-Woolley, Hughes et al. 1994; St Pierre and 
Tidball 1994). Indeed, macrophages appear to support the healing process in 
numerous ways. The ability of these cells to clear debris seems to be 
important in the healing process, as studies have shown that macrophage-
depleted recipients of myogenic cells undergo decreased levels of muscle 
regeneration (Lescaudron, Peltekian et al. 1999). Also, macrophages are 
known to induce apoptosis in neutrophils, thus reducing the level of secondary 
damage brought about by these cells (Meszaros, Reichner et al. 2000; 
Allenbach, Zufferey et al. 2006). Furthermore, in vitro studies have shown an 
increase in satellite cell proliferation when co-cultured with macrophages 
(Massimino, Rapizzi et al. 1997; Merly, Lescaudron et al. 1999; Cantini, 
Giurisato et al. 2002), although the exact mechanism of action remains 
unknown.  
But the relationship between neutrophils and macrophages in a muscle injury 
context could well be more complicated. In one study, using a dmx mouse 
model of Duchenne muscular dystrophy, mice with depleted macrophage 
populations showed dramatically reduced muscle membrane lesions 
(Wehling, Spencer et al. 2001). These results were followed up in a study in 
which  muscle cells co-cultured with neutrophils and macrophages in a 
physiologically relevant setting (Nguyen and Tidball 2003) showed a nitric 
oxide dependant, superoxide-independent mechanism of muscle cytotoxicity, 
implicating a possible role of phagocytes in muscle secondary injury. 
Also, it is well known that macrophages also have the ability to “turn nasty”. 
Activated by lipopolysaccharides (an outer membrane component of gram-
negative bacteria) or by the compliment system, macrophages can secret 
cytokines (e.g. Il6 and TNF-α) which up regulate the expression of adhesion 
molecules (facilitating neutrophil mobility) and increase capillary permeability 
(Roitti and Rabson 2000). In this activated state, they also provide a rich 
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source of nitric oxide (Cannon and St Pierre 1998). Thus, macrophages have 
the capacity to intensify an inflammatory response in the presence of 
pathogens. 
Finally, there also occurs tissue infiltration of cells involved in the adaptive 
immune response, most notably T-cells. T-cells are a unique subset of white 
blood cells which are involved in cell mediated immunity. These cells can be 
further sub divided into different populations (memory, helper, natural killer 
and cytotoxic as well as Regulatory and γδ cells) of T-cells with unique 
specialized functions. It has been shown that these cells might be involved in 
other non-immune functions in wound healing such as vascular remodelling 
(Mach, Schonbeck et al. 1999). Studies have also indicated that T cells (along 
with other immunological cells) might contribute towards survival and repair of 
neurons following peripheral axon damage (reviewed in (Sanders and Jones 
2006)). 
1.2.4 Inflammation: role of myotubes 
As previously mentioned, muscle tissue also performs an endocrine function.  
During inflammation, myotubes interact with immune cells and contribute in 
facilitating an immune response through the release of numerous cytokines 
and inflammatory mediators. It has been demonstrated that myotubes release 
IL1-β and TNF-α upon exposure to pro-inflammatory cytokines (De Rossi, 
Bernasconi et al. 2000). Similarly, incubating myotubes with TNF-α results in a 
decrease in TNF-receptor 1 (TNFR-1) expression as well as demonstrating a 
modulating function on cytokine expression (IL-9, IL-10 and IL-15) (Alvarez, 
Quinn et al. 2002).  
Another in vivo model demonstrated an increase in IL-6, transforming growth 
factor-beta (TGF-β), and granulocyte-macrophage colony-stimulating factor 
(GM-CSF), as well as an up regulation of intercellular adhesion molecule-1 
(ICAM-1) and human leukocyte antigen (HLA) class I and II in muscle 
following a  pro-inflammatory stimulus (Nagaraju, Raben et al. 1998). A recent 
study performed on an in vitro muscle injury model and on a muscle 
mechanical loading model demonstrated an increased release of neutrophil 
chemotactic molecules, as well as "priming" (activating) neutrophils toward the 
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production of reactive oxygen species (ROS) (Tsivitse, Mylona et al. 2005). 
Muscles thus appear to be active participants in the inflammatory response. 
 
Figure 1.4 Simplified representation of inflammatory progression accompanied by 
cell involvement. Adapted from (Witte and Barbul 2002) and (Li, Cummins et al. 
2001) 
1.2.5 Effect of fibre type on inflammatory 
  response 
Another interesting consideration is the possible role of fibre type on the 
inflammatory response. As mentioned earlier, oxidative muscle fibres tend to 
be more vascularised then fast-twitch glycolytic fibres. An injury sustained in 
these muscle groups are thus much more liable toward excessive 
haemorrhage brought about by capillary disruption.  
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This immediately intensifies the potential repercussion of oedema, as 
disruption of the immediate surrounding vasculature would lead to pronounced 
haemorrhage and exacerbate the local accumulation of blood. Furthermore, 
being more vascularised, one could expect an increase in the amount of 
immune cell trafficking taking place with, possibly, a more rapid (or 
pronounced) inflammatory response.  
On a metabolic level, one might intuitively expect a glycolytic fibre to have a 
greater marginal resistance to hypoxia, since these cells are geared towards a 
glycolytic/anaerobic, rather than an oxidative form of energy production. 
Furthermore, components like myoglobin (which as mentioned, is more 
abundant in oxidative fibres) might potentially denatured under low pH 
conditions (brought about by the local increase in lactate and CO2), liberating 
its iron centres. This could allow the iron to participate in Fenton reactions and 
increase oxidative stress through the formation of reactive species. 
Unfortunately, the literature did not afford much in terms of study results to 
indulge this curiosity. Two studies performed in rat models both mentioned a 
lower level of neutrophil invasion in white (fast-twitch) as opposed to oxidative 
muscles in an eccentric-biased contractile model (Tiidus, Deller et al. 2005) 
and in an excessive, high intensity exercise model (Morozov, Tsyplenkov et al. 
2006). 
1.3 Satellite cells 
Muscle fibres are terminally differentiated cells and thus, are unable to re-
enter the cell cycle. The fact that myotubes are not capable of proliferating 
brought up the question of a possible mechanism whereby post-natal muscle 
growth and regeneration could take place. Muscle mass can be expanded by 
increasing the amount of myofibres (hyperplasia) or by increasing the size of 
existing muscle fibres (hypertrophy). It was long known that myofibres seemed 
capable of increasing in size without undergoing nuclear division (Capers 
1960), and today, hypertrophy is a well documented phenomena (Frontera, 
Meredith et al. 1988; Lowe and Alway 1999). 
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The mechanism by which hyperplasia could take place eluded researches. 
However, one early experiment found that, muscle fibres could “split up” and 
each separately undergo hypertrophy (Reitsma 1969), thus increasing total 
muscle mass. But this was a relative rare event and could not completely 
account for the capacity of muscle to regenerate or increase in mass. 
In 1961 a huge contribution towards our understanding of the regenerative 
capacity of muscle was made. Utilizing electron microscopic, a small cell with 
a minimal amount of  cytoplasm, tightly wedged between a muscle fibre’s 
plasma membrane and the basement membrane was discovered  (Mauro 
1961).  
With regard to their cellular morphology and resident location, theses cells 
were subsequently dubbed satellite cells. Today, these cells are known to 
provide a replenishing pool of cells by which muscle tissue can recruit new 
myofibers (Collins, Olsen et al. 2005). These cells also act as nuclear donors 
to already existing muscle fibres and contribute towards muscle hypertrophy 
(Russell, Dix et al. 1992). 
This recruitment of myonuclei during hypertrophy takes place in the context of 
muscle adaptation: As previously described, muscle fibres bearing excessive 
contractile stress adapt by increasing the amount of contractile machinery 
which inevitably lead to an increase in cell volume. As each myonuclei is only 
capable of governing the transcriptional activity in a finite amount of space 
(Cheek 1985) additional growth thus requires the recruitment of extra 
myonuclei to accommodate hypertrophy. This recruitment is influenced by 
muscle fibre type, which is highly sensitive to contractile demand and is 
orchestrated by paracrine signalling factors (Allen, Monke et al. 1995).  
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Figure 1.5 Mechanism by which muscle tissue mass can be expanded with special 
reference to the role of satellite cells. 
 
Satellite cells are stem cell like progenitor cells of skeletal muscle with a multi-
potent phenotype (Zammit and Beauchamp 2001). Under normal conditions in 
matured muscle tissue these sells are quiescent (Schultz, Gibson et al. 1978), 
but can undergo vigorous proliferation in a regenerative context.  
This was demonstrated in a recent study were seven satellite cells associated 
with a single transplanted myofibre generated over a 100 myofibres, totalling 
thousands of myonuclei (Collins, Olsen et al. 2005). It has been shown that 
these cells, once activated, are capable to migrate to the site of injury 
(Schultz, Jaryszak et al. 1985). It has also more recently come to light that 
factors like nitric oxide and insulin-like growth factor (IGF) play some role in 
this mobilization process (Anderson and Pilipowicz 2002). 
1.3.1 Indentifying satellite cells 
In the past, electron microscopy was utilized to identify satellite cells on the 
basis of their cellular morphology and placement beneath the basal lamina. 
The advancement of immuno-histochemical techniques made it possible to 
identify satellite cells on the basis of their (semi-)unique transcriptional 
activities. Also, depending on the cell-cycle status, satellite cells might express 
unique proteins that can be used as markers to identify cell status. It should 
be noted though that this transcriptional activation takes place across a 
spectrum with no exact boundary. It is also generally accepted that there 
exists no all-encompassing marker for satellite cells (Montarras, Morgan et al. 
2005).
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Table 1.2 Adhesion molecules, membrane proteins and transcription factors 
typically used to identify satellite cells. The expression of each molecule  is temporally 
associated with different stages of differentiation. 
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Table 1.3 List of some transcription factors, adhesion molecules and structural 
proteins expressed by satellite cells and used to indicate metabolic state of cell as 
depicted in Table 1.2. Indicated by gray scale are  members of myogenic regulatory 
factors (MRFs) and grouped under  basic helix-loop-helix (bHLH) transcription factors. 
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1.3.2 Satellite cell response to injury  
Upon muscle injury, satellite cells are activated and recruited for muscle repair 
(Hill, Wernig et al. 2003). However, the exact processes involved in this 
satellite cell recruitment, and the subsequent modulation between proliferation 
and differentiation still remains to be fully elucidated. Injury induced by which 
ever means, result in a magnitude of cytokines and signalling molecules to be 
released. Strenuous exercise can give rise to elevated plasma levels of 
cytokines IL-8, IL-6, IL-1ra, IL-1β, IL-10 and TNF-α (Ostrowski, Rohde et al. 
1999; Ostrowski, Rohde et al. 2001). These effects can be compounded by 
the presence of neutrophils which, as stated, are capable of releasing IL-8, IL-
1, TNF-α and IFN-α (Fielding, Manfredi et al. 1993; Cassatella 1995; Tidball 
1995; Cannon and St Pierre 1998; Suzuki, Totsuka et al. 1999; Barbero, 
Benelli et al. 2001) as well as some unknown stimuli from macrophages 
(Massimino, Rapizzi et al. 1997; Merly, Lescaudron et al. 1999; Cantini, 
Giurisato et al. 2002). 
1.3.2.1 Satellite cell activation 
Despite this complex signalling environment, two major factors are well known 
to activate satellite cells. These are the signalling molecule nitric oxide 
(Anderson 2000) and the paracrine signalling peptide, hepatocyte growth 
factor/scatter factor (HGF/SF –hereafter simply revered to as “HGF”) 
(Tatsumi, Anderson et al. 1998; Miller, Thaloor et al. 2000). It should be noted 
that both neutrophils and macrophages (Salvemini, de Nucci et al. 1989; 
Moilanen and Vapaatalo 1995; Roitti and Rabson 2000) along with the 
endothelium (Salvemini, de Nucci et al. 1989) and mast cells (Salvemini, 
Masini et al. 1990) are capable of releasing nitric oxide.   
It has been shown that at least some macrophages (Morimoto, Amano et al. 
2001; Khan, Masuzaki et al. 2005) and neutrophils (McCourt, Wang et al. 
2001; Taieb, Delarche et al. 2002) are capable of secreting HGF. Many 
cytokines released during muscle injury might not have any mentionable effect 
on satellite cell activity, but might through their interaction with other cells 
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cause a release of both nitric oxide and HGF which might act on neighbouring 
satellite cells.  
 
Other factors of interest are fibroblast growth factor (FGF) which has been 
found to activate quiescent satellite cells (Johnson and Allen 1995). Also, 
satellite cells deficient in the heparin sulfate proteoglycan, syndecan-4 (a 
transmembrane protein) has been shown to have a delayed onset of satellite 
cell proliferation (Cornelison, Wilcox-Adelman et al. 2004). 
Both exercise (Keller, Steensberg et al. 2001; Tomiya, Aizawa et al. 2004) and 
inflammation (Kaplanski, Marin et al. 2003) induce a marked increase in local 
as well as systemic IL-6 concentration. Besides being released by cells 
involved in immunological responses,  IL-6 are also found to be released by 
vascular endothelial, fibroblasts (Akira, Taga et al. 1993),  myofibers exposed 
to non-injuring contraction (Brenner, Natale et al. 1999) and even satellite 
cells  (Cantini, Massimino et al. 1995). The effect of IL-6 on muscle is 
complex, demonstrating almost conflicting results. A slight increase in basal 
IL-6 levels is associated with muscle atrophy (Tsujinaka, Ebisui et al. 1995; 
Haddad, Zaldivar et al. 2005) while IL-6 have also been implicated in satellite 
cell activation (Cantini, Massimino et al. 1995).  
This proliferating effect seems to be mediated through NF-κB inhibition of 
differentiation (Langen, Schols et al. 2001). IL-6 also seem to have beneficial 
effects through its ability to attenuate an inflammatory response by stunting 
TNF-α production (Starkie, Ostrowski et al. 2003). Yet, the mediated 
physiological response might not be as straight forward, for  TNF-α have been 
shown to exert mitogenic effects on satellite cell (Li 2003) and are also 
implicated in myogenic differentiation (Li and Schwartz 2001). 
Irrespective of the preceding events, once activated, satellite cells exit the  G0 
phase of the cell cycle and commit to a state of proliferation (Grounds and 
McGeachie 1989). Orchestrating the recruitment of cell cycle machinery, the 
activated cells up-regulate their expression of a group of basic-helix-loop-helix 
(bHLH) transcription factors known as myogenic regulatory factors (MRF) 
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(Perry and Rudnick 2000) as well as  myocyte enhancer factor-2 (MEF2) 
(Naya and Olson 1999).  
Activated satellite cells also become highly mobile. Satellite cell’s sensitivity to 
chemotactic agents seem to be induced by growth factors like basic fibroblast 
growth factor (bFGF), hepatocyte growth factor (HGF), and insulin-like growth 
factor 1 (IGF-1) and mediated by signaling molecules, Ras and Ral (Suzuki, 
Yamazaki et al. 2000) . The ability of satellite cells to migrate to the site of 
injury is crucial, for it is in their ability to replace damaged or lost myotubes by 
differentiating into myotubes that satellite cells express their physiological 
relevance. 
1.3.2.2 Regulating satellite cell proliferation and self renewal 
The cell cycle-inhibitor p27Kip1 (also denoted as p27Kip1) (a cyclin-Cdk 
inhibitor) has emerged as a strong candidate for regulating cell cycle 
progression. It has been found to inhibit cell proliferation, even in the presence 
of a strong mitogenic stimulus (Spangenburg, Chakravarthy et al. 2002). Other 
growth factors also play a role, IGF-1 has the ability to down regulate p27Kip1, 
thereby increasing the proliferation capacity of satellite cells (Chakravarthy, 
Abraha et al. 2000). The presence of HGF also seems to contribute to satellite 
cell proliferation (Tatsumi, Anderson et al. 1998). 
Activated satellite cells must also have the ability to return to a quiescent state 
after proliferation in order to replenish the pool of cells. Little is known about 
how this return to a pre-proliferating state is orchestrated. Two models 
proposed for satellite cell renewal have been presented: a “stochastic” model 
by which cells randomly revert to a quiescent state without differentiating and 
an “asymmetric” model (Dhawan and Rando 2005). In this model, the first 
round of cell division gives rise to a daughter cell which might continue 
dividing whilst the mother cell exits the cell cycle and enters a state of 
quiescence again. 
Recently it has been demonstrated that satellite cells undergo self renewal via 
asymmetric segregation of template DNA (Shinin, Gayraud-Morel et al. 2006). 
What’s more, this selective segregation of “immortal” DNA template strands 
coincides with the polar segregation of the “cell-fate determinant” Numb 
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molecule. The dividing cell has a “Numb pole” which co-segregates with the 
daughter sell inheriting the original template DNA. This daughter cell also 
express the self renewal marker, Pax7 and does not differentiate.  
 
1.3.2.3 Satellite cell differentiation 
As mentioned, our interest in satellite cells is not in the fact that they are 
undifferentiated cells. Rather, it is their ability to differentiate and there by 
replenish lost tissue that they arouse our interest. This “replenishing capacity” 
effectively ordaining satellite cells as agents of homeostatic plasticity. In a way 
then, differentiation can be considered the most important aspect of satellite 
cells. After exiting the cell cycle, satellite cells (myoblasts) begin to fuse with 
each other, forming new myotubes. The cells start to produce the machinery 
necessary for contractile function: Contractile proteins are synthesized 
(Anderson and Davison 1999) and an increase in creatine kinase activity is 
observed (Florini and Magri 1989). 
All the events involved from activation to differentiation are carefully managed 
through a host of signalling events and are the collective result of multiple 
participating cell groups’. As a closing note, it is worth mentioning the 
exceptional sensitivity satellite cells have towards their environment. This was 
exquisitely demonstrated in a recent study where Conboy and co-workers 
evaluated the regenerative capacity of aged rats when cross-circulating 
bloods supply with a young rat. Monitoring different parameters of satellite cell 
physiology, it was shown that exposure of the old rat to factors in the young 
rats serum lead to a drastic increase in regenerative capacity (Conboy, 
Conboy et al. 2005). This study again demonstrated the significance of the 
environmental context in which physiological responses take place.  
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Figure 1.6 A basic schematic representation of sequential events taking place 
during satellite cell activation and the subsequent possible “routes” satellite cell 
progression might follow. 
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1.4 Treatment options 
A few clinical treatment modalities do exist to augment and facilitate muscle 
regeneration following contusion injury and these will very briefly be discussed 
here.  
1.4.1 Conventional intervention: supportive 
In general, muscle with or without any treatment will eventually (with respect 
to the extent of the injury) regenerate with a relatively good outcome. As such, 
most intervention is attempts to “tweak” the healing process in terms of the 
time it takes to regenerate or to minimize formation of scar tissue as well as 
secondary damage. 
Immediate treatment mostly comprises the RICE principal (rest, ice, 
compression, and elevation) which is aimed at reducing local haemorrhage. 
Currently there exist no proper (controlled) study to evaluate the effectiveness  
of RICE, although some of the independent components have been validated 
(Bleakley, McDonough et al. 2004). As far as rest is concern, immediate 
immobilization early on might be advantageous (Jarvinen 1975; Jarvinen and 
Lehto 1993). In a recent study, ice-massage of exercise-induced muscle 
damage seem to have no effect on muscle regeneration (Howatson, Gaze et 
al. 2005). Compression seemed to be beneficial in one study (Kraemer, Bush 
et al. 2001) whilst appearing to have no effect in another (Thorsson, Lilja et al. 
1997). 
Early mobilization (depending on the extent of the injury) has long been 
considered the best treatment after muscle trauma (Jarvinen 1976; Buckwalter 
1995; Kannus, Parkkari et al. 2003). Mobilisation has been found to induce 
vascularisation, earlier gain in muscle-fibre density (Jarvinen 1975; Jarvinen 
1976) and leads to improvement of contractile force generation in the injured 
muscle (Jarvinen 1976). This is of course dependant on the type and severity 
of the injury. It has also been shown that immediate mobilization can be 
detrimental to muscle regeneration and result in scar formation (Jarvinen 
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1975). In general, it is difficult to decide how early is too early and clinical 
experience seems to be of the utmost importance in evaluating each injury on 
a case by case basis.  
1.4.2 Therapeutic ultrasound 
Another prospective treatment modality to consider is therapeutic ultrasound. 
The exact mechanism of action regarding therapeutic ultrasound are not fully 
understood and the application and dosage seem somewhat arbitrary 
(Warden and McMeeken 2002). Typically the beneficial effects are found with 
regard to contusion injury in a rat model (Rantanen, Thorsson et al. 1999; 
Karnes and Burton 2002) where an increase in collagen deposition during the 
repair of tendon injuries was observed (da Cunha, Parizotto et al. 2001). 
1.4.3 Antioxidant therapy 
The rationale behind antioxidant therapy/antioxidant supplementation is the 
fact that excessive induced reactive oxygen species production is seen in the 
inflammatory response. Also, as mentioned, the secondary damage induced 
by neutrophils seems to be mostly mediated by an increase reactive species 
production (Welbourn, Goldman et al. 1991; Brickson, Hollander et al. 2001; 
Brickson, Ji et al. 2003). Neutralizing these radicals could reduce the degree 
of oxidative stress the muscle is exposed to and help prevent excessive 
muscle damage. 
Antioxidant therapy has been shown to reduce inflammatory damage 
(Cuzzocrea, Thiemermann et al. 2004). A more recent study has shown that 
muscle damage, induced by eccentric resistance training, can increase 
circulating bio-markers of oxidative stress. Treatment intervention involving 
antioxidant supplements (in the form of vitamin E and C) can attenuate the 
rise of these markers (Goldfarb, Bloomer et al. 2005). Antioxidant 
homeostasis is a complex system of which reactive species production is a 
totally normal (and indeed a necessary) part. It is yet unclear under which 
circumstance, and, in what extent antioxidant supplementation should be 
followed (Urso and Clarkson 2003). 
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1.4.4 Non­steroidal anti­inflammatory drugs  
Non-steroidal anti-inflammatory drugs (NSAIDs or NAIDs) are often prescribed 
for a vast array of muscle or other soft tissue injuries. The main controversy 
around NSAIDs is which parts of the inflammatory response is inhibited. As 
stated earlier, neutrophils are often associated with exacerbatiion of tissue 
damage, where as arrival of macrophages often herald the beginning of the 
reconstruction phase (by phagocytising cellular debris). It is preferential to 
inhibit the one but not the other, though it is questionable whether NSAIDs 
exhibit this specificity in terms of their pharmacodynamics. 
In a rat model, the effects of NSAIDs were evaluated after inflicting a 
contusion injury. Both satellite cell and fibroblast proliferation as well as 
capillary formation seemed unaffected (Thorsson, Rantanen et al. 1998). In a 
more resent study where a range of NSAIDs was injected, muscle injury was 
induced in mice by either injecting myotoxin or via crush injury. The 
application of NSAIDs did not seem to have any long-term negative effects on 
muscle recovery (Vignaud, Cebrian et al. 2005).  
Also, another study demonstrated increases in the microcirculatory system 
after administrating NSAIDs with specific cyclooxygenase-2 (COX-2) inhibitory 
capacity (Gierer, Mittlmeier et al. 2005). These results were accompanied by a 
reduction in platelet-dependent secondary damage and support tissue repair. 
Yet, NSAIDs might not be the panacea they appear to be. A freeze injury 
model performed on a knock-out mouse model demonstrated the requirement 
for COX-2 during early stages of muscle regeneration. In this study a 
decrease in inflammatory cells were observed as well as a reduction in the 
number of myoblasts (Bondesen, Mills et al. 2004).  This result was expanded 
upon by recent finding that some NSAIDs involved with COX-2 inhibition might 
mitigate the repair process by limiting myogenic precursor cells from fusing 
(Shen, Prisk et al. 2006). 
 
The COX-family of enzymes performs a catalytic function in the formation of 
prostaglandins. Prostaglandins in turn contribute to the regulation of multiple 
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physiological roles (basically all mammalian cells, with the exception of red 
blood cells, produce prostaglandins). These effects include the induction of 
pain and fever, regulation of blood pressure, induction of blood clotting, labour 
(among other reproductive functions), regulating circadian rhythm and of 
course, modulating the inflammatory response (Voet and Voet 2004).  
Recently if had been found that COX pathway play a role in muscle atrophy 
and possibly exert a regulating function on satellite cell activation and 
proliferation (Bondesen, Mills et al. 2006) hinting that inhibiting the COX-2 
pathway might compromise muscle growth. Furthermore, the extent to which 
inflammation is impaired could be detrimental towards wound healing. As an 
example, inhibiting macrophage infiltration would result in a reduction in the 
phagocytosis of cellular debris and delay wound repair. 
Currently, there is a substantial margin of incongruence in the literature 
regarding the efficacy of NSAIDs. If nothing else, caution should be applied in 
the general use of NSAIDs in treating muscle injury. 
1.4.5 Satellite cell grafting  
Muscle fibres have been successfully grafted from one muscle to another 
(Snow 1978; Mong 1988). The observed regeneration of grafted tissue is 
believed to be facilitated by the resident satellite cells co-grafted with muscle. 
The transplantation of viable satellite cells is another possible treatment 
option. Transplantation of satellite cells into extensor digitorum longus (EDL) 
muscle after “irreversible damage” results in remarkable (though not 
complete) recovery (Alameddine, Louboutin et al. 1994).  
The potential benefit of transplanting satellite cells was again dramatically 
demonstrated in a recent publication. Using a dystrophic dog model, it was 
shown that transplanted satellite cells expressing wild type allele greatly 
alleviated many of the symptoms induced by Golden retriever muscular 
dystrophy (GRMD) (Sampaolesi, Blot et al. 2006). The prospect of 
transplanting genetically modified satellite cells aside, this also demonstrates 
the ability of transplanted satellite cells to colonize and repair damaged tissue 
in a realistic in vivo model. Also, the transplantation of satellite cells in order to 
promote cardiac muscle regeneration is also considered (Menasche 2003). 
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Unfortunately, there are some limitations, one being immune rejection (which 
can be circumnavigated by performing autologous transplants) (Brent, Brooks 
et al. 1976; Partridge 2003). Furthermore, the spread of these cells cannot be 
localized and cell survival seem not to be optimum (Partridge 2003). Finally, 
the time and cost involved might currently not allow these procedures to 
become routinely performed as a treatment option for muscle injury.  
1.4.6 Photo­biostimulation 
The contentious field of low level laser therapy (LLLT) has, over the past 
decade, made striking claims in the fields of orthopaedics, dermatology, 
dentistry and physiotherapy (in both medical and veterinary disciplines).  With 
regard to recent findings, LLLT has been shown to decrease the inflammatory 
response following muscle contusion injury in a rat model (Rizzi, Mauriz et al. 
2006), reduce the formation of fibroses (Fillipin, Mauriz et al. 2005) and even 
delay the onset of muscle fatigue in conjunction with a reduction in muscle 
injury during episodes of excessive muscle contraction, albeit in an artificial 
ex-vivo setting (Lopes-Martins, Marcos et al. 2006). With regard to the 
shortcomings of many of the treatment modalities, this noninvasive procedure 
has, unlike many other forms of pharmacological intervention), very few 
contraindications (Navratil and Kymplova 2002) and would be a welcome 
addition to the currently, somewhat,  limited repertoire of treatment options 
available for treating muscle injuries. 
1.5 Low level laser therapy  
Both the phenomenon of photosynthesis as well as a child burning a piece of 
paper by focusing sunlight through a magnifying glass rest upon the principle: 
namely that light is propagating energy. In recent years, our ability to 
manipulate and direct this energy embodied in light has given rise to a host of 
innovations with which we have greatly increased our quality of life. The 
application of lasers in science has greatly expanded our experimental 
“toolkit”.  With lasers, membrane protein diffusion has been observed and 
(Yguerabide, Schmidt et al. 1982) and retinal nerve fiber layer measured 
(Lleo-Perez, Ortuno-Soto et al. 2004), nanotubes have been and continue to 
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be “forged” (Scott 2004), molecules dissected (Schiller, Suss et al. 2004), 
genomes are scrutinized (Ragoussis, Elvidge et al. 2006) and it has even 
enable the curious to intrude on the private lives of cells (Afonin, Ho et al. 
2006).   
In modern medicine, the dominant application of lasers is in their capacity as 
laser scalpels. Instead of mechanically cutting tissue, these surgical 
instruments can ablate tissue with micrometer diameter resolution, minimising 
“collateral” tissue damage as well as being perfectly sterile. The excellent 
precision and minimum damage make them especially popular in both neuro- 
and ocular surgery. 
In stark contrast to the powerful, high intensity YAG and CO2 lasers applied in 
tissue ablation, the power outputs used in LLLT are much lower. Indeed, LLLT 
induces its effect by non-thermal means. Moreover, LLLT is immersed in 
controversy and haunted by a lack of understanding as to how LLLT induces 
the biological effects seen following tissue irradiation. 
Regarding the cellular effects of LLLT, studies have shown an increase in 
collagen production (Reddy, Stehno-Bittel et al. 1998; Pereira, Eduardo Cde 
et al. 2002), increase in wound tensile strength (Stadler, Lanzafame et al. 
2001), promotion of regeneration of bone fractures (Trelles and Mayayo 
1987), a boost in DNA synthesis (Callaghan, Riordan et al. 1996), 
improvements in sperm viability (Ocana-Quero, Gomez-Villamandos et al. 
1997) as well as motility (Corral-Baques, Rigau et al. 2005) and altered the 
expression of over a 100 genes in human fibroblasts (Zhang, Song et al. 
2003). The clinical literature is full of reports showing the beneficial effects of 
LLLT, boasting literally thousands of articles on its seemingly miraculous 
healing effects.  Yet, justifying these results by the mechanism invoked by 
LLLT are painfully amiss in the literature. 
1.5.1 Historic overview 
It is probably difficult to pin-point the exact time and manner in which humans 
used the sun in the treatment of their ailments. Though earlier reports of 
heliotherapy (the medical application of sun light) are known, the first 
systematically documented use of sun in healing skin disease was by the 
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Hindu’s, described in the sacred text “Atharva-Veda”, more specifically, 
Ayurveda. The Ayurveda is a subsection of Atharva-Veda dealing with 
“wellbeing” and health (Fitzpatrick and Pathak 1959). This Hindu text dating 
back 1400 BC described the preparation of ointments prepared from the 
seeds of Psoralea corylifoliu were applied to vitiliginous skin before exposing 
the skin to direct sun light.  
During Napoleon’s campaign in Egypt (1798-1799) an astute man named 
Dominique Jean Larrey (who was responsible for many battlefield-medical 
initiatives, including the principal of triage) noted that ulcers healed more 
successfully if exposed to the sun (Bernhard 1926). Up to the time of the 
Second World War, this principal of “open air treatment” was followed until 
antibiotics became readably available. 
In 1903 Niels Ryberg Finsen received the Nobel Prize in Medicine and 
Physiology for his successful treatment of lupus vulgaris. What makes this 
such a unique incident is the fact that this would be the only time in the history 
of the Noble prize (for medicine) that it has been awarded in the field of 
dermatology. What is peculiar is the nature of the treatment: high dose UV 
radiation from a carbon arc lamp.   
Not so much of immediate importance to the medical discipline was August 6, 
1960. After being turned down by Physical Review Letters the first official 
publication of a laser was made (Maiman 1960) in Nature. This was after 
Theodore Maiman demonstrated the first working laser at Hughes Research 
Laboratories on May, the 16th 1960. It was remarked once that the laser is "a 
solution looking for a problem" (Garwin and Lincoln 2003). Today lasers are 
employed in a vast array of applications ranging from warfare to household 
appliances. 
In 1967 whilst exploring the carcinogenic effect of intense photon 
bombardment from a ruby laser on shaven mice, Mester noticed the irradiated 
group had their hair grow back faster than the control group (Mester, Szende 
et al. 1968).  This was the first report of laser bio-stimulation to be published. 
In the subsequent year, his group published more results (Mester, Ludany et 
al. 1968; Mester, Ludany et al. 1968) with the first publication of laser light as 
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a treatment modality in wound heal in 1971 (Mester, Spiry et al. 1971). Laser 
therapy was born!  
Here it should also be noted that LLLT involves a shift in the application of 
light. Whereas helio- and photo- therapy utilized damaging properties of light 
to treat infections, LLLT harnesses the stimulating effect of light. Indeed, at 
high dosages, LLLT seem to be useless or even detrimental (van Breugel and 
Bar 1992; Lopes-Martins, Marcos et al. 2006). 
1.5.2 Terminology 
Low level laser therapy, low power laser therapy, low level laser irradiation, 
low energy laser irradiation, photo bio-stimulation and some other associated 
terms are used interchangeably. This might lead to some confusion as some 
of the terms are also used in other fields with a different application of the 
phrase (e.g. “light therapy” is used to treat seasonal affective disorder and has 
absolutely nothing to do with photo-biostimulation). The phrase “laser therapy” 
would technically not be appropriate since light-emitting-diodes (LEDs) are 
also utilized, which produce incoherent light of a narrow-spectrum through 
electroluminescence and not by photon pumping as in lasers.  
Furthermore, it might be more prudent to emphasize the action rather than the 
instrument. Lasers and diodes are used in many other applications outside 
photo-biostimulation. Nevertheless, out of convention, these terms will be 
used interchangeably in this thesis. 
In the (serious) scientific literature, very little effort is made to distinguish 
between phototherapy and heliotherapy (the use of this terminology is usually 
at the discretion of the author). Technically, all forms of heliotherapy are 
indeed phototherapy as both use photons to treat patients. But heliotherapy, 
as the name implies, makes use of the sun as it source where as 
phototherapy make use of an artificial light source.  In effect, the “active 
ingredient” in sun light is the antimicrobial effect of UV rays. Eukaryotes 
generally have more sophisticated genomic repair mechanisms to handle 
ionizing radiation (Brown 2002). What’s more, the host (in this case humans) 
consists of a much larger bio-mass. Therefore, bombarding the infected 
wound with ionizing (UV) radiation is figuratively a “war of attrition”.  Both 
42 
 
heliotherapy and phototherapy (as used in this context) utilize the same 
central aspect namely, UV lights’ antimicrobial properties. 
In a similar way, the phrase “light therapy” (also, more ambiguously called 
phototherapy) is sometimes confused with LLLT. Light therapy as used in the 
treatment of seasonal affective disorder has absolutely nothing to do with 
LLLT: where as light therapy can influence circadian rhythm as well as other 
psychological mechanisms in an individual, LLLT influences cellular 
metabolism directly by somehow influencing the molecular machinery of 
individual cells. 
Finally, phototherapy and heliotherapy also have nothing to do with LLLT 
(though the term “phototherapy” is also sometimes correctly, but ambiguously, 
used in the context of LLLT). Whilst photo- and heliotherapy act via 
antimicrobial means, LLLT works by stimulating metabolic aspects of cellular 
routines.  Furthermore, UV light is sometimes used in LLLT, but rarely, as 
ionizing irradiation is mostly applied for its antibacterial properties. 
1.5.3 Resolving the controversy? 
Much of the support for LLLT rest upon findings in clinical trials. In essence, 
these studies are correlation studies where the irradiation of tissue, usually in 
some stressor context (e.g. inflammation of tendons, infection of gums, auto-
immune induced inflammation, contusion injury etc.) and the subsequent 
improvement is causally correlated to benefits endowed by LLLT. Expanding 
these studies from correlations to working hypothesis entering on a 
mechanism of action will give credibility to these types of studies. It is with this 
in mind that the field of laser therapy finds itself desperately pressed for an 
operational explanation to describe both the so-called “primary” and 
“secondary” mechanisms of action of LLLT.  
The absence of a mechanism of action also manifests in other challenges to 
the field of photo-biostimulation. There is great diversity in the experimental 
parameters used by both clinicians and researchers, including: wavelength; 
power density (intensity or "brightness" of the laser); total radiant exposure 
(total "dosage") not to mention cell-/animal-/tissue model and intervention 
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(toxicity, contusion injury, hypoxia etc) used.  This makes it rather difficult to 
compare the published studies and therefore the results.  
Because of the “aura of mystery” surrounding “laser therapy” (with special 
regards towards mechanism of action), many charlatans and proponents of 
pseudoscience find it fertile ground for their quackery. Amazing results can be 
published without giving explanations or predictions (in some instances peer 
review appears to be sadly lacking). The huge variations in parameters used 
and biological effects seen (in conjunction with the resulting confusion) 
present excellent camouflage for unscrupulous and fraudulent results.  A 
concrete mechanism of action might do much to remedy this problem since 
the physical events involved will dictate the parameters required for a given 
response and thus help develop a environment were studies can be readily 
reproduced by others in the field. 
Also, more insight is required on the “secondary” downstream effects of photo-
biostimulation. What interaction takes place between cells and their 
environment? Besides the signalling cascades, how does the cellular context 
influence the effect of LLLT? For instance, how does LLLT affect a myotube 
under normal conditions versus at the same cell in an injury setting (probably 
under ischaemic, low pH conditions, deprived of nutrients and exposed to high 
concentrations of calcium from ruptured sarcolemma)? Also, the micro-
environment of a cell changes as inflammation progresses (in fact, even the 
local composition of cell types changes as inflammation progresses).  How 
should treatment modalities be modulated over time?  These are complex 
questions. Undeniably, the inflammatory response itself is not fully 
understood, let alone the effect of a treatment modality like LLLT on the 
inflammatory process. 
1.5.4 Healing with light? 
Conceptually, using light as a treatment modality is somewhat of a departure 
from our current pharmacological perception, nurtured over the past century 
and still dominating our medical science. And clearly with good reason so.  
This paradigm has served us well and indeed it has increased our quality of 
life greatly over the last 100 years or so. With this in mind, it is somewhat 
44 
 
understandable that claims about LLLT are greeted with such scepticism by 
the medical fraternity, and even over the past 20 years, is still considered 
“fringe science” (or worse) in most scientific circles.  
If the field of LLLT are to dispel the mystic undertone imbued by it’s 
application of “glorified torch lights”, LLLT must be approach from a rigid 
scientific point of view. To genuinely complement our understanding, a new 
theory or (paradigm) must show a certain degree of connectivity with 
previously established empirical facts (see Popper (Popper 1972)). In this 
regard, LLLT has to uphold the previously established knowledge. If LLLT was 
a “tiny inland of knowledge” on its own, isolated from other fields and 
disciplines in science, it would be little more than an elaborate version of 
“chromo therapy”. 
All attributes of LLLT must therefore follow –unconditionally- the pre-existing 
laws of nature. One such law useful to our examination of LLLT biochemical 
mechanisms is the first law of photochemistry (also known as the Grotthuss-
Draper law)(Negi and Anand 1985). Simply stated, for all photochemical 
reactions to take place, light (photons) must be absorbed.  
In this regard, LLLT have earned it’s right to be legitimately investigated by a 
scientific methodology: it demonstrate connectivity with previously established 
scientific findings and make falsifiable claims which can be empirically 
investigated. Science is first and foremost a methodology. It does not regard 
what is investigated, but how it is investigated. If we forgo our squeamishness 
about using photons (which should not be of concern in the first place since 
photochemistry is a well established field) and look at the science, it should be 
clear that LLLT deserve an earnest and sincere consideration. 
1.5.5 Action­ and absorption spectrum: primary 
  and secondary mechanism of action 
The basic tenant behind LLLT rests upon the absorption of a photon by a 
molecule or molecular accessory-group acting as a photoacceptor (“pigment” 
or term used to describe chlorophyll, “photon antenna”). This absorption of a 
photon (also to be consider an event in which energy is transferred) must illicit 
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some biochemical effect and not simply sublimate the transferred energy as 
heat. The events leading form the absorbance and chemical transfer of 
energy, ultimately manifesting in some biological effect (increase H2O2, singlet 
oxygen formation, alteration in redox state of elements in the repertory chain 
etc.) is called the primary mechanism of action (Karu 1999).  
As with most other homeostatic mechanisms, downstream amplification-loops 
are believed to be involved. Whatever primary effect invoke by the absorption 
of a photon, this effect must ultimately have some effect on cellular 
metabolism (increase ATP or Ca+2) (Karu 1999). This “effect” is referred to as 
the secondary mechanism of action and ultimately lead to a phonotypical 
effect in cell biology. 
If photochemical reactions involve the absorption of light to mediate an effect, 
the fundamental question arises:  what molecules absorb light at which wave 
lengths and give rise to what kind of biological effect?  This biological effect 
can be plotted as an “biological action spectrum” (Karu and Kolyakov 2005). 
The biological action spectrum refers to the biological effect induced as a 
function of a specific wave length. In other words, it is the biological effect 
observed at each possible wave length. The criteria for an action spectrum are 
diverse. Sensibly, it must measure “units” which are indicative of an adaptive 
or advantageous process. As such, cell adhesion, DNA/RNA synthesis, ATP 
production, cell proliferation rate etc. have all been used. 
The “absorption spectrum” refers to the frequency (wave length) of light at 
which a molecule absorbs this light. To elicit some effect, a molecule must act 
as a photoacceptor. This photoacceptor must then somehow relay an effect to 
induce some biological outcome. Ideally, the molecule would absorb at the 
same spectrum that induces a biological action spectrum, i.e. it must produce 
some quantifiable biological response. Such scenario is illustrated in Figure 
1.7.   
Identifying these absorption-action spectrums is somewhat challenging. The 
problem lays in the complexity of the cell (both biochemically and optically). 
Many molecules interact with each other and thus change their optical 
properties. Also, the redox state of a cell might also influence the absorption 
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spectrum (Voet and Voet 2004). Biochemically, it is difficult to causally link a 
specific event to a unique result as many downstream effects are networked 
with a multitude of metabolic and signalling cascades.  
 
 
Figure 1.7 Schematic representation of a hypothetical absorption spectrum (red) 
with associated biological action spectrum (blue) of a candidate photoreceptor. This 
relationship between an absorption spectrum and biological action spectrum 
represent the basic principal through which photochemical mechanism can induce a 
biological response. 
1.5.6 LLLT: signalling and mediators of effect 
 
Work elucidating the action-absorption spectrum’s existence was pioneered 
by Karu (Karu, Kalendo et al. 1982; Karu 1984; Karu, Kalendo et al. 1984; 
Karu, Pyatibrat et al. 1987 ) who looked at DNA synthesis, (followed in later 
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studies by cell proliferation and adhesion) as possible candidate markers for a 
biological action spectrum.  In these early studies, flavoproteins (like NADH 
dehydrogenase) were hypothesised to act as photo acceptors in the blue light 
range. It was not long though until another strong candidate as photoacceptor 
emerged. 
1.5.6.1 Mitochondrial photon antenna: cytochrome c oxidase? 
It is well known that the mitochondria possess a group of chromophors (photo-
acceptors). The haem-groups of cytochrome exhibit highly characteristic 
absorbance spectra, depending on their redox state. Reduced haem-groups 
(Fe II) show specific peaks namely α, β and γ (Soret) bands (absent in the 
oxidized state).  
 
 
Table 1.4 Absorption spectrum of a few cytochromes in the electron transport 
chain (Voet and Voet 2004).   
 
 
This chromophore, in conjunction with the mitochondrion’s position central to 
energy production (as well the fact that it acts as a calcium store), has made it 
an attractive candidate as a mediator of photo-biostimulation  (Passarella, 
Ostuni et al. 1988; Greco, Guida et al. 1989). Cytocrome c specifically was 
long considered as a major mediator of LLLT (Pastore, Greco et al. 2000) and 
recently, a strong case was made for the legitimacy of cytochrome c oxidase 
as the photoacceptor in the near infrared spectrum (Wong-Riley, Liang et al. 
2005). 
It has been established that mitochondrial chromophore, cytochrome c 
oxidase is sensitive to He-Ne laser light (wavelength 632.8 nm) (Pastore, 
Greco et al. 2000). Recently, it has been observed that light of a certain wave 
length are able to induce the reduction of the photo-acceptor (wave length 
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might be dependent on cellular environment, for example the local redox 
state) (Karu, Pyatibrat et al. 2005).  
The author speculates that the rate limiting step in the electron transfer 
process within cytochrome c oxidase might be accelerated to provide more 
electrons available for the reduction of oxygen, as it is well know that electron 
excitation by light does in fact stimulate redox processes in other organic 
reactions. By increasing this flux in the rate limiting step, energy production 
can possibly be augmented. Though speculative, an increase in ATP 
production (capacity) could explain many of the global beneficial effects 
observed by LLLT. 
1.5.6.2 LLLT­ an increase ATP production? 
ATP, as the final product of cellular respiration is principally employed a 
cellular "currency" of energy. In our daily lives the activity of ATP is most 
salient in the role it plays as the energy molecule driving the molecular 
machinery which makes locomotion possible.  Each power stroke of the cross-
bridge cycle ends when an ATP molecule binds to the catalytic site of the 
MHC "head" section, allowing the actin-myosin complex to disengage. 
Depletion of ATP renders this process incomplete and the MHC and actin 
filament remain bound, leaving the muscle "rigid" and giving rise to the post-
mortem phenomenon of rigor mortis.  
Besides muscle contraction, cellular motility (assembly and disassembly of 
cytoskeleton) and intercellular motility (e.g. cell division) also demand ATP. 
ATP also plays an important role in signal transduction. For example, 
adenylate cyclase uses ATP as substrate in the production of the signalling 
molecule cAMP, as do kinases in the phosphorylation of proteins. ATP is also 
utilised in DNA polymerisation as well as transcription. Indeed, ATP is utilized 
in a multitude of cellular activities.  
It is also interesting to note that the first published study done on the beneficial 
effect of red light on ATP production was published about 3 months before the 
first working laser was published (Gordon and Surrey 1960) (and about 7 
years after the dawn of LLLT). In the field of LLLT, an increase in ATP 
production following LLLT has been observed in vitro (Karu, Pyatibrat et al. 
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1995) and it was recently found that LLLT was able to delay skeletal muscle 
fatigue in an in vivo model (Lopes-Martins, Marcos et al. 2006). These results 
would be consistent with an increase ATP flux model. Furthermore another 
recent study demonstrated the protective effect of LLLT after irradiating 
neurons poisoned with cyanide (Wong-Riley, Liang et al. 2005). It was found 
that neurons treated with cyanide showed increased viability after receiving 
LLLT. Since the emission spectrum of their lasers coincide with the absorption 
spectrum of cytochrome c, it was hypothesised that this increase in cell 
viability was induced by an increase in cellular respiration to compensate for 
cyanide poisoning.  
Cellular death usually takes on the form of either apoptosis or necrosis 
(another “type” of cell death is autophagy but is not relevant to this thesis). 
Apoptosis, also known as programmed cell death (PCD), is, as the name 
implies, a well orchestrated process which requires energy (ATP). Its hall 
mark is the “neat-and-tidy” death of a cell in which cellular components are 
“packaged” in membrane vesicles and “tagged” by phosphatidylserine (Li, 
Sarkisian et al. 2003) for non-inflammatory phagocytosis (Majno and Joris 
1995). Necrosis on the other hand is well known to induce inflammation by the 
spilling of obnoxious cellular debris (Majno and Joris 1995). Thus, an increase 
in ATP production might facilitate a speedy resolution of an inflammatory 
response by facilitating apoptotic cell death.  
As the cellular utility of ATP is truly immense, any modulating effect on ATP 
production could induce profound effects. As ATP is of such importance, an 
increase in ATP could greatly benefit cellular wellbeing and possibly make 
cells more resistant to homeostatic challenges. Alternatively, it could also 
facilitate a shift in cellular death mechanism from necrotic to apoptotic which 
might attenuate subsequent inflammatory damage in an injury setting. 
1.5.6.3 Increased reactive species production? 
Reactive species (RS), including reactive oxygen species (ROS) have been 
implicated in a host of cellular responses, ranging from inflammation to cellular 
proliferation. The cellular response to ROS seems to be mostly dependant on 
the dose, where a low, transient increase seems to be more beneficial toward 
“cellular wellbeing” (Thannickal and Fanburg 2000; Hancock, Desikan et al. 
50 
 
2001; Pantano, Reynaert et al. 2006). These effects are also influenced by 
cell type and probably, the signalling context and cellular micro-environment. It 
is also believed that the effects of LLLT might be mediate through radical 
signalling mechanisms. These mechanisms as well as evidence pertaining to 
the role of LLLT in this ROS signalling induction will be briefly discussed. 
1.5.6.4 ROS as a signalling molecule 
It is no coincidence that ROS evolved as a signalling molecule. By virtue of its 
chemistry, is an excellent cell signalling molecule, able to have short quick 
responses which can just as quickly be removed. H2O2, not being a free 
radical, is relatively stable with a half life of about 1 ms as compared to O2-· 
with a half life of about 1 µs (Reth 2002). Also, since the molecule is not 
charged, it is one of the few reactive species that will readily diffuse across 
membranes.  
H2O2 also demonstrates a level of specificity, mostly targeting cysteine 
containing proteins (more specifically, cysteine thiolates) (Forman, Fukuto et 
al. 2004). Under physiological conditions, cysteine can take on the oxidative 
state as disulfide (-S-S) or sulfenic acid (-SOH). Since most cysteine amino 
acids have a pKa of about ~8.5, they are protonated. However, if the cysteine 
residue is in close proximity to a positively charged residential amino acid, the 
pKa can be dropped and the cysteine takes on its thiolate anion (-S-) form, 
rendering itself susceptible towards oxidation by hydrogen peroxide (Reth 
2002). These chemical aspects insure a level of signalling specificity for H2O2 
induced signal transduction. 
Finally ROS lies central to energy production and can relay important 
information regarding the state of cellular metabolism and ATP production. 
Thus, ROS acts as the principal signal transduction molecule in mitochondrial 
retrograde cell signalling. In a sense, ROS acts as a metabolic “trip-switch”, 
capable of influencing multiple signalling cascades in orchestration with other 
cellular signalling events. 
1.5.6.5 ROS signal transduction 
ROS, as well as the change in cellular redox state, have been shown to 
modulate cell responses in numerous models. Interestingly, a host of 
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cytokines and growth factors have been found to increase cellular ROS 
production (reviewed by (Finkel 2000)). ROS also have a multitude of 
downstream signalling targets and effectors. As an example, NF-κB, a 
transcription factor influencing gene expression of over a 100 proteins, has 
been found to be sensitive to cellular redox state and ROS production 
(reviewed by (Pantano, Reynaert et al. 2006)).  
In an insightful study recently performed on melanoma cells using an in-situ 
photo-generation bacteriochlorophyll-based sensitizer, the effect of intrinsically 
produce ROS was monitored. Controlling the level of ROS production by 
modulating the dose of light, ROS was observed to dose dependently 
modulate p38 and its cellular distribution in a phosphorylated state.  
Other cellular signalling responses were also investigated by monitoring the 
behaviour of mitogen-activated protein kinase (MAPK), extracellular signal-
regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and Akt (Posen, 
Kalchenko et al. 2005). A dose dependant reaction was observed, where 
vigorous generation of ROS seemed detrimental and mild dosage beneficial.  
Extreme proliferation via radical induction has also been shown to take place 
independent of JNK or MAPK. By stably transforming fibroblasts with a 
constitutively active isoform of p21 (Ras), H-RasV12, it was shown that large 
amount of superoxide (·O2-) was produced. This radical production coincided 
with intense proliferation which could subsequently be abolished by the 
addition of antioxidant N-acetyl-L-cysteine (NAC). It was also found that 
MAPK activity decreased while JNK remained inactive in the H-RasV12-
transformed cells, indicating that these responses took place independent of 
JNK/MAPK activity (Irani, Xia et al. 1997). 
In order to maintain proper homeostasis, signals must be able to be “turned-
on and off”. One such family of molecules responsible for “turning off” 
activated signals are protein phosphatase (PTP).  These enzymes are, as the 
name indicates, capable of de-phosphorylating molecules. By such action, low 
molecular weight phosphotyrosine protein phosphatase (LMW-PTP) are 
capable of inactivating the receptors of platelet-derived growth factor (PDGF) 
(Berti, Rigacci et al. 1994) and insulin (Chiarugi, Cirri et al. 1997). LMW-PTP 
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is known to be reversibly inhibited by H2O2-induced oxidation of two amino 
acids (Cys-12 and Cys-17) in its catalytic pocket  (Caselli, Marzocchini et al. 
1998). It thus follows that an increase in H2O2 could effectively prolong a 
PDGF and insulin mediated effect by increasing the half-life of their 
phosphorylated (activated) state. This same example of redox signalling have 
more recently also been observed in other PTP’s (Kamata, Shibukawa et al. 
2000; Lee and Esselman 2002). Considering the important role that 
phosphorylation plays in cell signalling, these redox sensitive manipulations of 
receptor phosphorylation could have a drastic impact on cellular metabolism. 
Also, since H2O2 is dominantly derived from mitochondrial activity, it also 
represents a mitochondrial retrograde signalling pathway. 
1.5.6.6 ROS and the mitochondria 
Some reactive species are too reactive and unstable to either diffuse far or 
exhibit reasonable specificity (both essential characteristics of signalling 
molecules). In general, it is difficult to elucidate the type of ROS being 
produced given that these reactive molecules are quickly transformed. In the 
mitochondria, superoxide (•O2-) is quickly dismutased to hydrogen peroxide 
(H2O2), a more stable molecule able to defuse across the inner mitochondrial 
membrane.  
Central to the in-vivo function of ROS are mitochondrial respiration.  The 
electron transport chain (ETC) “leaks” reduced oxygen, namely superoxide, 
which under normal conditions undergoes rapid conversion to hydrogen 
peroxide, in a reaction catalysed by superoxide dismutase (SOD), an enzyme 
found in both mitochondria and cytosol. H2O2 thus represents the major 
radical derivative of mitochondrial ROS production found in the cytosol of the 
cell.  
Mitochondrial activity has been shown to be necessary in ROS signalling in 
cardiac myocytes. During short-term exposure to hydrogen peroxide, the 
ERK/MAPKs signalling cascades were activated, but subsequently loss this 
activation function after inhibition of complex III of the ETC by administrating 
myxothiazol (Bogoyevitch, Ng et al. 2000). Similarly, mitochondrial ROS have 
also been shown to activate c-Jun N-terminal kinases (JNK) via increased 
release of mitochondrial H2O2 (Bogoyevitch, Ng et al. 2000). 
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A fascinating study by Hughes et al. 2005 (Hughes, Murphy et al. 2005) made 
use of a mitochondria specific antioxidant (Mito Vit E) in order to explore 
specifically the role of mitochondrial ROS in apoptotic signal transduction. 
Administration of Mito Vit E enhanced TNF-induced apoptosis in U937 cell. It 
was found that under normal conditions following TNF stimulation, maximal 
binding of NF-κB to transcription motifs was induced within 15 min.  
Treating cells with Mito Vit E (and thus depleting ROS of mitochondrial origin) 
resulted in a substantial delay, only reaching maximum DNA-binding activity 
60 min after TNF treatment. The researchers concluded that ROS are 
produced in the mitochondria in response to TNF treatment, and, that by 
scavenging these mitochondrial ROS, NF-κB activation was down regulated. 
NF-κB, in turn, can no longer bind as efficiently to transcription motifs of anti-
apoptotic genes, thus resulting in a defective anti-apoptotic signal 
transduction. 
1.5.6.7 Reactive Species ­ mediators of LLLT? 
Reactive species have also long been considered a possible agent for 
mediating signal transduction events induced by LLLT (Karu 1989) and many 
studies have provided support for photochemical induction of ROS, believed 
to be mostly mediated through changes in mitochondrial systems (Karu, 
Pyatibrat et al. 1987 ; Callaghan, Riordan et al. 1996; Grossman, Schneid et 
al. 1998; Alexandratou, Yova et al. 2002)  
Recently  it was found that LLLT (here using a 904 nm, 45 mW laser with a 
dose of 5 J/cm2) modulated the inflammatory response by attenuating ROS 
production and inhibiting NF-κB activation (Rizzi, Mauriz et al. 2006). There 
was also a reduction observed in the activity of iNOS. The author concluded 
that LLLT reduced oxidative stress, thereby down regulate NF-κB activation 
and thus inhibited NO production (via reduced iNOS expression).  
These results are difficult to interpret and the conclusion drawn from these 
results should be done with caution. For one thing, LLLT need not have any 
direct effect on ROS production to observe these results. As a hypothetical 
possibility, LLLT could have promoted an increase flux of electron and thus 
increase ATP production (similarly, as will be discussed below, LLLT could 
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have disassociated NO from cytochrome c, leading to an increase in ATP 
production).  
With more energy, cells could engage in apoptosis instead of necrosis which 
would dramatically reduce inflammatory response. With a decreased 
inflammatory response, the subsequent activation of NF-κB and iNOS 
production would not take place -not because of any direct effect of LLLT on 
them, but simply because the signal to invoke an immune reaction was down 
played by a shift in cellular death from necrosis to apoptosis.  
1.5.6.8 Local transient thermal effect? 
Part of the energy passed on to an electron when absorbing a photon is 
converted to heat. This causes a local increase in the heat at the point of the 
chromophore. It has been hypothesized that this localised, transient increase 
in temperature could result in the conformational change of some enzymes 
(Letokhov 1991). This might either activate or inactivate them and thus 
influence metabolism.  
1.5.6.9 Antimicrobial effect? 
Acne vulgaris (or simply acne) is usually treated with topical bactericidal 
agents or antibiotics as well as hormonal treatment to control sebum 
secretion. It has also been found to be successfully treated with intense blue 
light (wavelength 407–420 nm)(Kawada, Aragane et al. 2002; Ashkenazi, 
Malik et al. 2003). Coproporphyrin III (a porphyrin) produced within the acne 
causing bacterium P. acnes has been found to produce free radicals when 
irradiated by light at the near UV spectrum (<420nm) (Kjeldstad 1984; Nouri 
and Villafradez-Diaz 2005). It is believed that this increase in reactive species 
ultimately cause cell death by means of excessive oxidative stress and so 
reduce the incidence of acne. Interestingly, superior results were obtained 
when used in conjunction with red light (Papageorgiou, Katsambas et al. 
2000; Charakida, Seaton et al. 2004; Elman and Lebzelter 2004; Goldberg 
and Russell 2006). It is rather tempting to speculate on the possible 
mechanistic nature of this synergism between blue and red light. While blue 
light might actually kill the bacterium via the photochemical induction of 
radicals, the red light might ease an inflammatory response or simply incite 
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epithelial cell rejuvenation, facilitate deposition of protein matrix forming the 
basal lamina or by some other means. 
1.5.6.10 NO inhibition of cytochrome c 
Nitric oxide is chemically rather peculiar compound, and physiologically of 
great importance, so much so that it was named molecule of the year in 1992 
(Koshland 1993). It has a single unpaired electron on the nitrogen atom which 
affords NO it’s signalling and functional specificity to bind to iron in haem-
groups. NO has been shown to increase fibroblast proliferation (Du, Islam et 
al. 1997) as well as be involved in satellite cell activation (Anderson 2000).  
Recently, using a new bioluminescence imaging technique, it has been shown 
that LLLT decreases the number of inflammatory cells, whilst simultaneously 
increasing the expression of iNOS (Moriyama, Moriyama et al. 2005). 
Furthermore, NO has been shown to play a possible role in the induction of 
apoptosis via mitochondrial retrograde cell signalling (Brown and Borutaite 
2002; Moncada and Erusalimsky 2002; Brune 2003). Adding conviction to this 
view is the discovery of a unique mitochondrial nitric-oxide synthase (mtNOS) 
(Elfering, Sarkela et al. 2002). Also, the ability of NO to induce mitochondrial 
biogenesis is also well established (Clementi and Nisoli 2005). 
Nitric oxide’s capacity to inhibit cytochrome c oxidase has been well known for 
more than a decade (Brown and Cooper 1994; Cleeter, Cooper et al. 1994) 
and its ability to reversibly attenuate mitochondrial respiration has since been 
verified (Solien, Haynes et al. 2005). Both oxygen and NO compete for the 
same binding site, resulting in the reversible inhibition of the ETC by NO. 
Because of this reversibility, the inhibition of mitochondrial respiration is 
postulated to be a physiological mechanism by which cellular energy 
production can be modulated (Brown and Borutaite 2002; Moncada and 
Erusalimsky 2002).  
Since this process is reversible, the amount of oxygen available in the system 
under investigation should be kept in mind when considering the inhibitory 
effect of NO on the ETC (Solien, Haynes et al. 2005; Mason, Nicholls et al. 
2006). Most in vitro studies done on isolated mitochondria are performed at 
un-physiologically high levels oxygen saturation (Solien, Haynes et al. 2005). 
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Indeed, studies done in a more physiological range have shown that the 
inhibitory effect of NO can be amplified under hypoxic conditions (Solien, 
Haynes et al. 2005; Mason, Nicholls et al. 2006). 
This is of great interest in muscle injury, especially in a contusion injury model. 
As mentioned, ruptured arteries and the hematoma that arise reduce the 
amount of oxygenated blood reaching the cells in the surrounding contusion 
injury. One would naturally expect the micro-environment of these cells to be 
hypoxic in nature and would thus lead to a greater susceptibility of cytochrome 
c inhibition by NO competition. As mentioned, neutrophils, macrophages 
(Salvemini, de Nucci et al. 1989; Roitti and Rabson 2000), endothelial cells 
(Buga, Gold et al. 1991) and mast cells (Salvemini, Masini et al. 1990) are 
capable of releasing NO during an inflammatory response, making the 
inhibition of ETC more likely. 
Finally, NO can also lead to the irreversible inhibition of cytochrome c. This 
irreversible inhibition is believed to be mediated through the conversion of NO 
to peroxynitrite (via radical interaction) and the subsequent damaging effect of 
the peroxynitrite on the respiratory machinery (Sharpe and Cooper 1998; 
Mason, Nicholls et al. 2006). It should be noted that the inhibition of the ETC 
by NO might increase the leakage of superoxide from within the mitochondria, 
a process which might allow the superoxide to interact with NO to form 
peroxynitrite. 
It has long been known that light can cause NO to dissociate from cytochrome 
c oxidase (Boelens, Wever et al. 1983), but only at low temperatures (less 
than -223 ˚C). Of special interest is the more recent finding that relatively low 
levels of light under physiological temperature (37˚C) appear to be able to 
reverse the inhibitory effect of NO on respiration (also note, this study was not 
performed in a LLLT context) (Borutaite, Budriunaite et al. 2000). Of note, the 
author did not systematically investigate the wavelength of the light source. It 
was found that a band pass filter with a maximum transmission at 425 nm 
(specifically, <390 nm and >480 nm exclusion width) was still effective at 
abolishing the NO-induced respiratory inhibition.  
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Figure 1.8 Short illustration of postulated primary and secondary mechanisms by 
which LLLT may exhort a photo-biostimulatory/inhibitory effect. Abbreviations: ROS- 
reactive oxygen species; COX- cytochrome c oxidase. 
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1.5.7 Influence of muscle fibre type on LLLT 
The simple view that “a muscle is a muscle” simply is not true. In the previous 
section, some variation on fibre type and the physiological adaptation this 
tissue undergo was mentioned. This was not done purely out of academic 
interest, but also to voice the importance and the (somewhat neglected) need 
to accommodate tissue specific interaction with light. 
Many mechanisms of action centre on the mitochondria and its associated 
chromophors. As mentioned, oxidative fibres tend to have a higher 
mitochondrial density. This immediately implies a possible increase in photo 
acceptor capacity of these cells and the accompanying increase in sensitivity 
towards photo-biostimulation. To date, not a single article has been produced 
investigating the effects of LLLT on different fibre types in skeletal muscle.  
Similarly, other structural and metabolic considerations are also neglected. 
The differences in vascularisation and satellite cell density (to name but a few) 
are not addressed in the literature with regard to LLLT. 
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1.6 Hypothesis 
Muscle is one of the few tissue types that can substantially regenerate itself. 
Though muscle regenerative capacity is considerable, it is not always perfect 
(Plant, Beitzel et al. 2005). Furthermore, it is slow, and, especially in the 
context of professional athletes, augmenting the regeneration process is 
highly sought-after.  
We hypothesise that the photo-biostimulatory effects of LLLT (at a wavelength 
of 638 nm) can incite cellular events involved in energy metabolism and cell 
viability/proliferation in skeletal muscle stem cells (satellite cells) both in vitro 
and in vivo. Specificly, it is hypothesised that these even 
 
1.7 Aims 
1. Establish an in vitro model of satellite cells in culture in order to evaluate 
the effects of LLLT, specifically measure LLLT’s effects on cell viability and 
metabolic activity and investigate possible mechanisms of action of any 
effects seen. 
 2. Establish an in-vivo (Wistar rat) model of contusion injury to explore the 
effects of LLLT.  
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2. Chapter 2  
Materials and Methods 
2.1 C2C12 in vitro model 
For the in-vitro part of this project, C2C12 cells, obtained from European 
Collection of Cell Culture (ECACC), were utilised.  C2C12 cells are muscles 
progenitor cells, allowing us to explore certain aspects of muscle regeneration 
in this model.  Furthermore, there already exists a robust protocol set up in our 
laboratory for growing and maintaining these cell cultures.   
Cells were maintained in T75 flasks (Greiner, France) prior to experimental 
procedures. Cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) (Sigma, South Africa) supplemented with 10% foetal calf serum 
(Highveld Biologicals, South Africa) and 4 mM GibCo L-glutamine (Invitrogen, 
Carlsband, CA, USA).  Cells were passaged at a confluence of 60% ~ 65%.  
Cells between passage 8-12 were used for experiments. With the exception of 
the experimental treatment, all cells were maintained at 37○C, in a 5% CO2 
and 95% relative humidity incubator.  
 
For experimental purposes all cells were maintained in a phenol red free 
DMEM supplemented as above (Higveld Biologicals, South Africa). To the 
best of our knowledge, the effect of phenol red in cell culture is negligible, 
although it has been found to be a weak agonist  of the  oestrogen receptor 
(Berthois, Katzenellenbogen et al. 1986). All cells used as control groups were 
also incubated in the phenol red free media. 
2.1.1 Experimental Protocols 
Experiments were performed in a 37○C incubator without any manipulation of 
humidity, CO2 or O2. Control groups were exposed to identical conditions for 
the same time interval as corresponding experimental groups. Laser power 
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output was checked prior to the commencement of the experiment using an 
Ophir laser power meter and a calibrated power head (Ophir, Israel). The 
arrangement of equipment used during irradiation is illustrated in Figure 2.1.  
Irradiation time was adjusted to ensure that all cells received equal “doses” 
(Table 2.1) of laser irradiation (60 mW).    Power dosage was calculated as 
follows: 
 
Laser power: 60 mW 
Petri dish diameter: 60 mm = 6 cm 
Petri dish area:   п d2/4 = п x (6cm)2 /4   (п = Pi) 
= 28.27 cm2 
 
Power density on Petri dish  = 60 mW/28.27 cm2 
= 2.12 mW/cm2 
 
W = J/s    [Power (in Watt) = Energy (in Joules) / time (in seconds)] 
 
Dosage for treatment is always reported on in J/cm2 
 
Dosage = Power density x irradiation time 
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Figure 2.1. Diode laser focusing barrel inside modified incubator (A). The actual 
laser itself was mounted outside next to the experimental incubator (B). Schematic 
representation of irradiation rig inside modified incubator (C). 
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Table 2.1  Basic parameters of diode laser and dosage calculations 
Irradiation time 
(min) 
Dose 
(J cm-2) 
5 0.636 
15 1.908 
30 3.816 
 
2.1.2 Cell Irradiation  
Cells were grown up to appropriate confluency (~65%), trypsinized, counted 
and diluted in medium, to provide a seeding density of 1100 cell/cm2 in 60/15 
mm Petri dish (Greiner Bio One,) with 3 ml medium. The  Seeded cells were 
left to adhere for 6 hours after which cells were irradiated for the required time 
at 37○C.  
Thirty (30) minutes of irradiation as the optimal dose and as such, all 
experiments were performed accordingly (refer Chapter 3).  After irradiation, 
cells were placed back into in environment controlled incubator and a MTT 
assay was performed 24 hours later. 
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Figure 2.2  Basic outline of laser intervention on C2C12 cells. 
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2.1.3 Effect of Antioxidants on irradiated cells  
To observe the effect of antioxidants on irradiated cells, two membrane-
permeable antioxidants, namely N-Acetyl-Cysteine (NAC) and N-(2-
mercaptopropionyl)-glycine (MPG) were used. The respective concentration 
(NAC: 30 µM and MPG 10 µM) were chosen as they have been previously 
shown to be effective at scavenging mitochondrial ROS (Lacerda, Smith et al. 
2006). 
Cells were grown up to appropriate confluency (~65%), trypsinized counted 
and diluted in medium to provide a seeding density of 1100 cell/cm2 in 60 mm 
Petri dish (Greiner Bio One) with 3 ml medium. The intervention setup is 
outlined in Figure 2.3 and will briefly be discussed here.  Seeded cells were 
left to adhere for 6 hours after which medium was aspirated and the cells 
washed three times with PBS before adding medium containing the 
antioxidant (either NAC or MPG). Control cells also had a media changed with 
new media as well as washing steps, but without any antioxidant 
supplementation in the media. Cells were left for a pre-irradiation incubation 
period of 15 min. Thereafter, cells were either irradiated for 30 minutes or 
incubated under the same conditions (control) for 30 minutes as previously 
described.   
After the intervention session, the antioxidant media was aspirated and cells 
were gently washed with PBS (three times) and new media was added.  Cells 
were again incubated for 24 hours before the MTT assay was performed.   
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Figure 2.3 Basic outline of laser intervention on C2C12 cells treated with 
antioxidants. PhR+ and PhR– represent media change with (+) and without (-) phenol 
red in media respectively. 
2.1.4 MTT assay 
The MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay 
is an indirect, high-throughput approach to evaluating cell viability/cell 
metabolism  (Mosmann 1983; Janjic and Wollheim 1992). The assay depends 
on the ability of mitochondrial succinate dehydrogenase to reduce the MTT, 
thereby cleaving the tetrazolium rings forming blue-purple formazan crystals 
which are water insoluble and membrane impermeable. It should also be 
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noted that some formazan is also produced in cytosolic fractions of cells 
(Berridge and Tan 1993; Gonzalez and Tarloff 2001; Bernas and Dobrucki 
2002).  
As a result, viable cells (which, by implication, have uncompromised 
membrane integrity) will accumulate formazan. Dead cells will either not be 
able to produce formazan, or will have any formazan produced removed 
during decantation step. The cells are lysed by applying a detergent, releasing 
the formazan which is dissolved in an appropriate solvent (in this case, 
acidified isopropanol). The amount of formazan can then be calculated 
spectrophotometrically at an absorption maximum roughly between 500 and 
600 nm (depending on solvent applied). 
Since the assay depends on mitochondrial activity, it is use to deduce cell 
viability. Introducing different control groups allow the standardization of cell 
viability.  By comparing MTT absorbance of control groups with corresponding 
intervention groups, a dose response curve can be deduced to evaluate the 
effect of different treatment regimes. Factors that might compromise MTT 
accuracy include cell volume, reagents in culture media as well as chemicals 
applied in intervention groups (Wang, Ge et al. 2006). Overall, the MTT assay 
has been show to be robust indicator of cell viability (or at the least cellular 
metabolism) (Mosmann 1983; Janjic and Wollheim 1992; Gonzalez and 
Tarloff 2001).  
2.1.5 MTT procedure 
Media was decanted and cells were washed with pre-warmed PBS (37°C) 
after which cells were incubated in 0.25% m/v MTT solution (MTT dissolved in 
PBS) for 2 hours in an incubator at 37˚C. The MTT solution was then 
decanted (if cells remained adhered to plate) and 1.5 ml solvent (0.1% Triton-
X added to 1% isopropanol in a 1:51 ratio) is then added. Cells were left on a 
shaker for 5 minutes to ensure the formazan product is thoroughly dissolved. 
Dissolved formazan solution is then transferred to 2 ml opaque/lightproof tube 
and centrifuge (multispeed refrigerated centrifuge: ALC international SRL, 
Milano, Italy —model PK121R) for 2 min at 109,564 g.  The absorbance of the 
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supernatant is then measured at 540 nm (blanked with solvent) in Varian 50 
spectrophotometer.  
2.1.6 Effect of LLLT on Cell signalling events  
As previously described cells were handled, seeded and irradiated according 
to the normal irradiation protocol described earlier. At time intervals of 5 min, 
15 min, 60 min, 24 and 48 hours post-irradiation, medium was decanted from 
the cells and they were then  washed with ice cold PBS. Ice cold lysis buffer 
(RIPA buffer -see Addenda for chemical constituents) was added and cells 
were scraped manually. Cell debris in the RIPA buffer suspension was 
sonicated before freezing aliquots at -80ºC. Protein content was determent by 
Bradford technique (Bradford 1976).  
 
Figure 2.4 Basic outline of protein harvesting time points for Western blot analysis 
(irradiation procedure as described in Figure 2.1 was followed). Red arrows denote 
time points at which cells were sacrificed. T-0 (red asterisk) denotes time after 
irradiation. 
2.1.6.1 Western blot analysis 
Either 20 or 30 μg of whole cell protein was loaded onto a 10% polyacrylamide 
gel (with a 4% stacking gel to load samples) and separated according to 
molecular weight by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). In order to assess band weight, a pre-stained 
protein ladder (Bio-Rad Laboratories, California, USA) was loaded onto each 
gel. 
Gels were  run at 200 V (400 mA) for 1 hour and subsequently transferred to a 
polyvinylidine fluoride (PVDF) membrane (Immobilon, Millipore, USA) using a 
semi-dry method (Bio-Rad Laboratories, California, USA) at 15V, 500 mA for 
60 minutes (see Addenda). 
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Membranes were blocked in a 5% (w/v) Elite© non-fat milk powder prepared 
in Tris Buffered Saline-Tween 20 (TBS-T, 0.05% v/v) for at least 2 hours at 
room temperature. Membranes were washed 3 times in TBS-T prior to  
incubating with primary antibodies (1:1000, diluted in TBS-T) overnight at 4 
˚C. Following 5 washes (0.05% TBS-T), membranes were incubated with 
horseradish peroxidase-conjugated secondary antibody (1:1000 diluted in 
TBS-T) (anti-mouse: Dako Cytomation, Denmark) for 2 hours at room 
temperature. 
After washing membranes, an enhanced chemiluminescence kit (Amersham 
Bioscience, UK) was used to detect protein-antibody localization on the 
membrane. Bands were visualized on x-ray film (Hyperfilm, Amersham 
Bioscience, UK) and quantified by densitometry with UN-SCAN-IT©  (Silk 
Scientific, Utah, USA). 
2.1.7  Effect of LLLT on antioxidant status 
There exist many seemingly conflicting reports on the role of LLLT on ROS 
production. Some studies claim LLLT to increase ROS production (Callaghan, 
Riordan et al. 1996; Grossman, Schneid et al. 1998; Kim, Pak et al. 2000) 
while other advocate an attenuating effect on ROS production (Vladimirov, 
Gorbatenkova et al. 1988; Berki, Nemeth et al. 1991; Potapov, Trepilets et al. 
1995; Fujimaki, Shimoyama et al. 2003). The basic mechanism and chemistry 
of the ORAC assay itself is described in the Chapter 4 of this thesis. Here the 
procedure followed in ORAC assay will be briefly discussed. 
2.1.7.1 Reagents preparation of ORAC 
Standards were made up fresh for each reaction from aliquot Trolox stock 
solutions. A standard curve was prepared by making a dilution range with  
75 mM phosphate buffer (pH 7.4) at according dilution points: 200, 100, 50, 25 
and 12.5 µM.  
 
Fresh 153 mM  2,2'-azobis(2-aminodinopropane)-dihydrochloride (AAPH) was 
made up for each reaction. 0.414 g AAPH was dissolved into 10 ml ice cold  
75 mM phosphate buffer (pH 7.4) and kept on ice. 
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A 5×10-3 mM fluorescein stock solution was prepared and kept in a light 
protected container at 4 ○C which, if stored as explained, is viable for several 
months (Huang, Ou et al. 2002). A fluorescein working solution (8.16×10-5 
mM) was made up fresh for each run. 
 
Cell samples as well as blood plasma were diluted ×75, while tissue were 
diluted ×200 (w/v) in 75 mM phosphate buffer (pH 7.4). Both cell and tissue 
sample were sonicated  (Versonic 300; The Virtis Company, Inc;  Gardiner, 
N.Y;seting 3). Tissue samples were spun down via centrifugation for 30 min, 
8853 g at 4ºC (multispeed refrigerated centrifuge: ALC international SRL, 
Milano, Italy —model PK121R). Supernatant was immediately used for ORAC 
assay. Protein content of snap-frozen samples as well as cell lysate were 
measured by Bradford technique (Bradford 1976). 
   
Basic plate loading “architecture” is described in Chapter 4. A 96 well black 
plate was used, but only 48 (half the plate) was employed in each run. 
Samples were run in triplicate. Into each well 25 µl of sample standard or 
blank (phosphate buffer) were added. With the aid of a multi-pipette, 150 µl 
fluorescein working solution (8.16×10-5 mM) was added. The plate was then 
incubated at 37○C inside the temperature controlled plate reader for  
10 minutes before adding 25 µl AAPH. Fluorescent intensity was logged at 
one minute intervals for 180 minutes (thus, 180 readings). 
2.1.7.2   ORAC calculations 
By plotting the relative florescent intensity over time, a curve is generated from 
which the area under the curve (AUC) can be calculated, according to the 
formula: AUCtotal = 0.5 + ƒ1/ ƒ0 + ... ƒi/ƒ0 + ... + ƒ179/ ƒ 0 + ƒ180/ ƒ0  
(Were ƒ0 representing initial fluorescence at time point zero, ƒi after i amount 
of reading intervals) 
To compensate for any background fluorescent signals produce by scattering, 
reflection or nonspecific excitation, the value obtained from a blank was 
subtracted from each sample or Trolox standard: 
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Net AUC = (AUCsample or Trolox – AUCblank) 
 
Figure 2.5 Typical ORAC curves. If Blue sample represent a blank, Red’s net AUC 
would be obtained by (value of Red – value of Blue). Applying the same formula for 
Green sample (value or Green – value of Blue) would produce Greens sample’s net 
AUC. Calculating the net AUC, antioxidant status of different samples can be 
compared. Graphs of samples with lower antioxidant capacity would have a steeper 
decay profile, resulting in a smaller AUC.  
 
The Trolox standard AUC was plotted against a corresponding Trolox 
concentration to produce a regression curve. The equation of this curve was 
used to express ORAC results as Trolox equivalent units: Substituting net 
AUC value into X produce Trolox equivalent value expressed as µmol Trolox 
per litter of sample. Homogenized muscle was expressed as Trolox per litter 
of sample per µg protein (see Addenda). Finally, all sample values were 
multiplied by the dilution factor.  
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Figure 2.6 Antioxidant (trolox) standard curve of respective sample concentrations 
plotted against Net area under the curve (AUC). Because of the large gap between 
200 µmol and 100 µm, samples were inspected for linearity by omitting the 200 µmol 
concentration interval. 
 
The exact same protocol as in the previous irradiation studies was followed. 
Cells were harvested at the same time points as the Western blot protocol to 
investigate different possible alterations in cellular redox state over time. Cells 
were scraped in ice cold PBS.  
2.2 In vivo experimental model  
All procedures on experimental animals were performed according to the 
guidelines set forth by the Animal Ethics Committee (Sub-Committee B) of 
Stellenbosch University. All animals were provided and housed by the Small 
Animal Unit at the Departments Physiological Science at University of 
Stellenbosch. 
Our department has a well established protocol for the handling and 
processing of Wistar rodents. Wistar generally have a good temperament and 
are easily handled. Furthermore, for the purpose of intervention (contusion 
injury and laser irradiation) Wistar rats were of optimal size.  Male Wistar rats 
were used in this study.  
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Animals were randomly allocated into groups of four rats per cage. 
Temperature was kept constant a 21ºC with room ventilation rate of 10 
changes/hour. A 12/12 light-dark cycle was maintained (light 6:30-18:30). 
Animals had access to food (standard rat chow) and water ad libitum. To allow 
the rats to get accustomed to the researcher, animals were handled daily and 
weighed three times a week. Mean weight was 371.03g ± 49.24 g at the start 
of the experimental protocol.  
2.2.1 Experimental groups 
As already mentioned animals randomly allocated into groups of four and 
were housed in standard cages (Techniplast, Italy). Animals exhibiting any 
signs of illness or injury were excluded from the study.  
The animals were divided in to one of four groups: 
• Injured control (In) 
o Rats only received contusion injury 
 
• Irradiated control (Ir) 
o Rats only received irradiation session (30 min) 
 
• Irradiated and Injured (Ir+In) 
o Contusion injury was inflicted, folowed by irradiation session (30 min) on 
  the injured leg 
 
• Sham (S) 
o No injury or irradiation, but rats were anesthetised and leg was shaven. 
 
This basic group allocation was repeated to produce a corresponding time 
point on 4 hr, 24 hr, 48 hr and 72 hr, with each group consisting of 4 animals. 
Thus, four interventions groups each at four time frames with four animals in 
each group resulted in a total of 64 rats used in this study. 
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Figure 2.7  Basic outline of experimental group allocation, intervention and 
subsequent analysis. 
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2.2.2 Anaesthetics 
Prior to any intervention (irradiation and/or contusion injury) animals were 
anaesthetised (75 mg/kg ketamine, 0.5 mg/kg medetomidine, i.p.). Whilst 
anaesthetised, one hind limb was shaved clean using an electric clipper.  
2.2.3 Irradiation 
Before intervention, laser power output was confirmed using an Ophir laser 
power meter fitted with a calibrated probe (Ophir, Israel). The temperature of 
the animal was maintained by placing the animal on paper towels and 
covering the body of the animal with bubble-wrap. The shaved limb was 
manoeuvred into position, supported by folded tissue paper, under the diode 
focus barrel. A flexible, thin sheet of cardboard with a circle cut out in the 
centre (diameter = 2 cm) was placed against the shaven leg to insure only the 
section of leg protruding from the circular gap was irradiated. The leg was 
irradiated for 30 min with a 60 mW diode laser, providing the following dosage: 
Table 2.2 Dosage calculation for irradiated groups. 
Irradiation time 
(min) 
Dose 
(J cm-2) 
30 34.28 
 
2.2.4 Injury  
In collaboration with the Central Engineering Service, Stellenbosch University, 
a drop-weight system was designed to induce a contusion injury. The system 
allows one to vary the weight and height of a metal bar that runs in a guide to 
have an impact on the tissue placed underneath it, thus inducing a contusion 
injury.  The system has been characterised in our department and the height 
and mass requirements previously determined. This system permit for a highly 
standardized contusion injury with a high degree of reproducibility. A 
schematic of the injury rig is shown in Figure 2.8.  
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Figure 2.8  Basic setup of contusion injury rig. Illustrated is a diagrammatical 
representation of skinned rat leg, showing rudimentary anatomical landscape with 
gastrocnemius muscle indicated in light red.   
 
 
2.2.5 Sample acquisition  
Tissue was collected from animals at the following time points: 4 h, 24 h, 48 h 
and 72 h. Animals were euthanized by administering an overdose of 
Pentobarbitone sodium (200 mg/kg i.p.). 
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Blood was collected by cardiac puncture into the right ventricle through direct 
visualisation of the heart following opening of the chest, using a 20 gauge 
needle and a 5 ml plastic syringe.  Blood was immediately placed into 
heparinised Vacutainers (Becton-Dickinson, South Africa), gently mixed and 
placed on ice. Rats were sacrificed in groups of 2 to ensure blood (as well as 
tissue) samples collected could be frozen as quickly as possible (sample 
collection was completed within 90 minutes).  
After sample collection, the whole blood was centrifuged at 3000 g for 10 
minutes at 4 ºC. Plasma was aliquotted into 1.5 ml tubes and stored in -80 ºC 
for analysis. 
Directly after collecting blood, the gastrocnemius muscle was processed. 
Access to the clean muscle was gained by cutting through the pelt, fat and 
connective tissue with a sharp scissor. Afterwards the leg was skinned by 
pulling back on the loosened pelt. The muscle was removed by cutting 
through the tendons before being immersed into ice cold PBS saline to wash 
of any hair or debris. The muscle was cut with a scalpel till only the central 
median section remained. 
 
Figure 2.9  Diagrammatic representation of a gastrocnemius muscle. Red border 
indicate the excision boundaries of a typical biopsy. Dark-gray scale correspond to 
the section used for immunohistochemical analysis were as the light-gray scale 
represent section snap frozen in liquid N2.   
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2.2.6 Histology 
During biopsy, the excised gastrocnemius muscle is cut as indicated in Figure 
18 and placed in a 10 % formaldehyde-saline solution for 72 hours at room 
temperature. It is placed afterwards into an embedding cassette before being 
positioned into the tissue processor (TISSUE TEK III, model 4640B, Lab-Tek 
division, Miles Laboratories Inc, Napervile, IL). The precise process is 
discussed in the Addenda. In brief, the formaldehyde fixed tissue is 
dehydrated, impregnated with paraffin wax (Histosec, Merck).  Following this 
the sections are blocked in more paraffin wax, mounted and sectioned into 5 
µm diameter slides on a rotary microtome (Reichert Jung, Heidelberg, 
Austria). 
2.2.7 H&E staining  
Haematoxylin and eosin progressive staining or simply, H&E staining was 
used for histological inspection contusion injury and the accompanying 
inflammatory response. The procedure is discussed in the Addenda. 
Haematoxylin stains basophilic structures (acidic cell components which most 
notably include nucleic acids in the cell nucleus and the endoplasmic 
reticulum) a blue-purplish colour. The fluorescent red dye, eosin is used as a 
counter stain which binds to basic cell components (e.g. proteins in cytoplasm 
and red blood cells). 
The staining procedure is described in the Addenda. After staining, slides 
were air-dried and a cover slip mounted on the sections using mounting 
media.  Sections were, and visualised at 200 and 400 x magnification on a 
Nikon Eclipse E400 microscope equipped with a Nikon DXM1200 colour 
camera. Photographs were taken of the main anatomical structure of the 
tissue, but no formal analysis was performed on H&E staining samples.  
These sections were used to investigate the extent and severity of the injury 
and to ensure that the injuries were consistent in all animals. 
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2.2.8  Immunohistochemistry 
There currently exists no all-encompassing marker for satellite cells 
(Montarras, Morgan et al. 2005).  However, CD 34, a glycoprotein functioning 
as a cell adhesion factor (Beauchamp, Heslop et al. 2000; Hwang, Yuk et al. 
2004; Shi and Garry 2006) and N-CAM (CD56) (Crameri, Langberg et al. 
2004; Sinanan, Hunt et al. 2004; Olsen, Aagaard et al. 2006) another 
glycoprotein involved in cell adhesion, have both been shown to be, at the 
very least, reasonable markers and are regularly applied (as observed in the 
literature). Satellite cells were thus co-stained with these two markers to 
increase the fidelity of our analysis. Nuclei was stained for with 4',6-diamidino-
2-phenylindole (DAPI). Muscle fibres are easily identified by their structure 
and do not require any staining. 
2.2.8.1 Slide preparation and staining 
Each slide, containing ~4 cross sections, was dewaxed and rehydrated before 
being incubated in a 0.1 % Trypsin bath for 20 minutes at 37 ºC. The 
immunostaining procedure is stipulated in the Addenda, but will briefly be 
discussed here. At all time exposure to intense light was avoided as all 
fluorescent probes being used during staining are liable to photo-bleaching. 
Also, sections were never allowed to dry out and were kept in a humidified 
container. Sections on slides were encircled with a wax pen to isolate sections 
and prevent unnecessary spillage of applied reagents. Nonspecific binding 
sites were blocked by incubating the sections with 5% serum of animal in 
which secondary antibody was raised (in this case, donkey serum) for 30 
minutes at room temperature before draining off serum.  
Primary antibody (rabbit-anti-NCAM) was added and left at room temperature 
to incubate for 4 hours. The primary antibody was then washed off with 0.1 M 
PBS and sulforhodamine 101 acid chloride (Texas Red) conjugated 
secondary antibodies (donkey anti-rabbit) was added and incubated over night 
at 4ºC. The following day, sections were rinsed with PBS and incubated with a 
second primary antibody (mouse anti-CD34) for 40 minutes at room 
temperature. After rinsing the section, it was incubated for 30 min at room 
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temperature with the second secondary antibody (donkey anti-mouse) which 
was conjugated to fluorescein isothiocyanate (FITC). Directly afterwards 
(without rinsing of the previous antibody), the fluorescent stain 4',6-diamidino-
2-phenylindole (DAPI) was added and incubated for 10 minutes. The slide 
was then rinsed in PBS and gently flicked to remove exess PBS before adding 
florescent mounting media (Dako, Diagnostech) and a cover-slip. PBS 
negative controls (PBS without primary antibody) were included to test the 
specificity of antibodies. 
2.2.8.2 Image visualization  
Sections were visualized under Nikon ECLIPSE E400 Fluorescence 
Microscope, equipped with a colour camera (Nikon DXM 1200) for 
photomicroscopy. Each section had six fields-of-view imaged and 
photographed randomly (injured muscles were photographed near the border 
zone of the injury). Pictures were taken using a 40× objective under all three 
excitation beams (by manipulating excitation wavelength filter) to visualize 
DAPI, FITC and Texas Red florescent-probes. 
Table 2.3  Absorption-emission spectra of florescent probes. 
 
Using the computer program Simple PCI (version 4.0, Compix Inc., Imaging 
Systems, USA), the separate images were overlaid to produce a multi-
coloured image, containing the blue (DAPI), red (Texas Red) and green 
(FITC), allowing the images to be viewed as a single image.  This allowed for 
scoring of satellite cells by counting cells co-stained for N-Cam (Texas Red), 
CD34 (FITC) and visible nuclei (DAPI). Muscle fibres were also counted and 
the final satellite cell score was stated as satellite cells per myofibers. 
Scoring was done by inspecting overlaid photos taken of cells. Co-staining 
with a red and green probe produced a strong yellowish signal when overlaid, 
with a small nucleus outside the myofibrillar space (but slightly indented). In 
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case of multinucleated satellite cell “niches”, each nucleus was counted as a 
satellite cell. 
 
2.2.9 Statistical analysis 
Results are expressed as mean ± standard error of the mean (SEM).  Data 
were analysed using one way analysis of variance (ANOVA) followed by the 
Dunns post-hoc test (nonparametric) or a Bonferroni post-hoc test 
(parametric).  p<0.05 was considered significant.  
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3. Chapter 3  
Results 
3.1 In vitro results 
Murine C2C12 cells grew well in our hands in the laboratory.  Cells were 
utilized between passages 8 and 12.  Cells which had become more than 70% 
confluent were not used in setting up experiments.  Cell cultures were visually 
inspected for signs of infection or contamination.  Figure 3.1 shows a 
representative photo of healthy cells in culture. 
 
 
 
 
Figure 3.1. Representative image of murine C2C12 satellite cells in culture. Phase 
contrast image with a green filter (20 x objective). 
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3.1.1 MTT activity in irradiated satellite cells 
The activity of the mitochondrial enzyme measured by the MTT assay 
increased in an irradiation-time-dependent manner, with a significant increase 
in MTT activity seen with 30 mins of 638 nm laser irradiation (196.8 ± 16.2% 
vs control values of 100%, n=6, p<0.001, see Figure 3.2).  As a significant 
increase was seen at 30 mins (3.816 J cm-2) this irradiation time was utilized 
in all subsequent experiments.  
 
Figure 3.2  Effect of 5, 15 and 30 minute 638 nm laser irradiation on MTT 
conversion in murine C2C12 satellite cells. n=6-9, *** p<0.001 vs Control.  
 
3.1.2  MTT­antioxidant study 
 
Inclusion of the antioxidants MPG and NAC in the cells for 15 mins prior to 
irradiation resulted in a decrease in the MTT activity measured (to 114.6 ± 
4.9% and 121.8 ± 3.3% respectively, normalized to control).  The MTT activity 
was significantly decreased, when compared to 30 min laser irradiation, in the 
MPG treated group (p<0.05, n=9).  However the result with NAC was not 
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significant when compared to the 30 min laser irradiated group (p>0.05, n=9).  
There was still a significant increase in MTT activity in the NAC treated group 
(p<0.05, n=9) when compared to the control group (see Figure 3.3). 
 
 
 
Figure 3.3 Comparative analysis of MTT values between irradiated but not 
antioxidant treated (laser/no-AOX) groups and two irradiated groups which have been 
treated with one of two antioxidants (either NAC or MPG). Laser groups receiving 
antioxidants demonstrated significant (P =0.0365) increases in MTT values. 
 
3.1.3 Cellular antioxidant status (ORAC ASSAY) 
The ORAC assay on the irradiated cells showed that the laser irradiation 
lowered the cellular ORAC value by 47.6 ± 18.3% from the control value 5 
minutes after a 30 min irradiation by a 638nm laser (3.816 J cm-2).  This 
decrease was however not significant (p>0.05, n=4).  In addition a rebound 
increase in the ORAC value was seen 15 min post laser irradiation, with an 
increase of 51.7 ± 47.3% from control values.  Again this was not significant 
(p>0.05, n=4).  The ORAC value returned to control levels 60 min post 
irradiation (see Figure 3.4).   
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Figure 3.4 ORAC values for cells irradiated for 30 min at 638 nm (3.186 J cm-2).  
Cells were harvested and assayed at the time points indicated after the completion of 
the laser irradiation. n=4. 
3.1.4 Western blot analysis 
Following the findings given above (that the laser irradiation appeared to be 
having some effect on cellular function), it was decided to look at the 
activation state of several well known intracellular signalling pathways.  Of the 
pathways investigated (Akt, STAT-3, AMPK and p38 MAPK) Akt and p38 
showed immediate increases in phosphorylation state following 30 mins of 
laser irradiation at 638 nm (3.186 J cm-2), with relative increases of 88.6 ± 
26.3% (p<0.05, n=4; see Figure 3.5) for Akt phosphorylation and 23.0 ± 5.1% 
(p>0.05, n=3; see Figure 3.6) for p38 phosphorylation. STAT-3 
phosphorylation showed no change (data not shown), however total STAT-3 
levels increased by 17.2 ± 11.4% at 60 min post laser irradiation (p>0.05, n=3; 
see Figure 3.7).  Phosphorylated AMPK levels showed no significant change 
at any of the time points investigated (data not shown). 
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Figure 3.5 Relative increase in Akt phosphorylation status across indicated time 
points. * p<0.05 vs Control, n=4. 
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Figure 3.6 Relative increase in p38 MAPK phosphorylation status across indicated 
time points. No significant differences were found. 
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Figure 3.7 Relative increase in total STAT-3 at 60 min post laser irradiation.  
p>0.05, n=3. 
 
3.2 In vivo model 
The contusion injury model has been developed and tested in house, with 
validation of the model and the effects in-vivo being carried out by another 
post-graduate student in the department.  As a result of the findings in this 
study the following parameters were chosen for the injury: 
  Drop height: 50 cm 
  Drop mass:  200 g 
These parameters gave a reproducible contusion injury which was healed 
over a period of 14 days. 
Excision of the injured muscle and subsequent histology (using H & E 
staining) was used to confirm the injury (see Figure 3.8). 
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Figure 3.8 H&E stain of normal uninjured muscle (left) and injured (right) (400 x 
magnification). Note red blood cells, a result of vascular disruption (arrow).  
 
With the use of the laser in-vivo, and with the time constraints in mind, a single 
irradiation time of 30 mins (giving a dose of 34.28 J cm-2) was chosen.  All 
animals tolerated this level of irradiation with no macroscopic signs of damage 
to the skin. 
3.2.1 ORAC results 
Following injury, blood and tissue was collected at various time points to allow 
for determination of both plasma and muscle antioxidant status using the 
ORAC assay.  As can be seen in Figure 3.9 both irradiation and injury resulted 
in changes in ORAC values at both 4 and 24 hours, although these changes 
were not significant (p>0.05, n=4). 
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Figure 3.9 Normalised ORAC values for plasma from Sham (control) , irradiated 
and injured animals.  Samples were collected at the time points indicated (p>0.05, 
n=4). 
 
 
When the injured animals were treated (30 min irradiation, 34.28 J cm-2) there 
was a (non-significant) decrease in plasma ORAC values (see Figure 3.10). 
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Figure 3.10 Normalised ORAC values for plasma from Sham (control), injured and 
injured/irradiated (treated) animals.  Samples were collected at the time points 
indicated (p>0.05, n=4). 
 
In accordance with the results seen in the plasma, changes in the ORAC 
values in the muscle tissue also changed.  As can be seen in Figure 3.10 both 
irradiation and injury resulted in changes in the ORAC values of the muscle at 
both 4 and 24 hours, although these changes were not significant (p>0.05, 
n=4). 
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Figure 3.11 Normalised ORAC values for muscle tissue from Sham (control) , 
irradiated and injured animals.  Samples were collected at the time points 
indicated (p>0.05, n=4). 
 
In addition ORAC values also changed in the injured animals following 
treatment at both 4 and 24 hours (see Figure 3.11).  As with the plasma 
values these changes were not significant (p>0.05, n=4). 
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Figure 3.12 Normalised ORAC values for muscle from Sham (control), injured and 
injured/irradiated (treated) animals.  Samples were collected at the time points 
indicated (p>0.05, n=4). 
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3.2.2 Satellite cells 
 
Following injury satellite cell number (measured as CD34/CD56 positive cells 
per myofibre) was assessed.  For a cell to be counted as a satellite cell it had 
to contain a nucleus and stain positive for CD34 and CD56.  Examples of 
positive cells are shown in Figure 3.12. 
 
 
 
Figure 3.13  Markers of satellite cells:  A) CD34, (FITC - green), B) N-Cam/CD56, 
(Texas Red - red), (DAPI – blue, a nuclear stain).C) Micrographs above are overlaid 
(representation of A and B).  Indicated at “A” is a satellite cell stained positive for both 
markers. Encircled at “B” is a central myofibre nuclei – indicative of a newly 
regenerated fibre. 
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Following injury satellite cell numbers increased at 4 hours (from 0.021 ± 
0.002 to 0.028 ± 0.004 satellite cells per myofibre; p>0.05, n=4-16).  This 
transient increase appeared to be sustained for 72 hours (see Figure 3.13). 
 
 
 
 
Figure 3.14   Satellite cell number per myofibre at the given time points 
following injury. 
 
Laser irradiation (638 nm) of the hind limb containing the gastrocnemius 
muscle for 30 min (giving a dose of 34.28 J cm-2) had no effect on satellite cell 
numbers, as determined by CD34 and CD56 co-staining (see Figure 3.14). 
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Figure 3.15  Satellite cell number per myofibre at the given time points following 
638 nm laser irradiation. 
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Laser irradiation of the injured muscle (one treatment of 30 min with a 638 nm 
laser giving a dose of 34.28 J cm-2) had no effect on satellite cell number in 
the first 48 hours post treatment.  At 72 hours a slight (non-significant) 
decrease in cell number was seen (see Figure 3.15) 
 
Figure 3.16  Satellite cell number per myofibre in injured and treated (638 nm 
laser irradiated, 34.28 J cm-2) at the given time points following injury. 
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4. Chapter 4 
Discussion 
4.1 MTT results: laser irradiation 
and antioxidant treatment  
 
The laser irradiation study, in conjunction with the antioxidant study clearly 
demonstrated an increase in MTT value in irradiated groups, whilst antioxidant 
treatment seems to abolish the major beneficial effects. The results can be 
summed up by five critical observations:  
 
• 30 minutes seems to be the optimum dose.  
• The magnitude of change (almost 200% above baseline for irradiated cells).  
• The fact that the responses were persistent and still manifested 24 hours 
 post irradiation. Antioxidants abolished this effect. 
• Antioxidant groups demonstrated a (modest) increase in MTT values. 
 
Antioxidants are known to abolish cell signalling involving reactive oxygen 
species (e.g. Mito Vit E (Hughes, Murphy et al. 2005) and NAC (Irani, Xia et 
al. 1997)).  Since antioxidants abolish the increase in MTT values seen 
following irradiation, it is reasonable to expect some form of redox signalling is 
involved in these cellular effects. In this regard, NF-κB (Pantano, Reynaert et 
al. 2006),  MAPK, ERK, JNK (Bogoyevitch, Ng et al. 2000) and Akt (Posen, 
Kalchenko et al. 2005)  have been implicated in ROS signalling. Furthermore, 
the ability of H2O2 to reversibly inhibit LMW-PTP (Caselli, Marzocchini et al. 
1998) could directly influence the phosphorylation status of a multitude 
signalling receptors. Deducing which of these signalling cascades are involved 
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and are responsible for the biological effects observed is open for future 
studies. 
 
By whichever mechanism invoked, this effect must also give rise to longer 
term alterations in cellular events, as the MTT results were measured 24 hour 
post irradiation. The pronounced increase in MTT results is perplexing. At first 
glance, one would expect the result to be indicative of cell proliferation. This 
however becomes somewhat unlikely when one is confronted with the fact 
that this would imply the cells are doubling at a rate which will make all but the 
most prolific eukaryote cells shy. Furthermore, considering the spatial 
restriction in a Petri dish, cells would most probably be too confluent and stop 
dividing (via contact inhibition). 
 
But if cell proliferation on its own cannot account for the increased MTT 
values, an alternative must exist. Before embarking on a discussion of these 
results, explaining the assay itself might illuminate some aspects of what 
exactly was observed in relation to the characteristics of the assay.    
 
4.1.1 The MTT assay 
In essence, the MTT assay makes use of two attributes of a cellular status to 
infer cell viability and proliferation: total activity of mitochondrial succinate 
dehydrogenase and membrane integrity. The amount of cell viability is 
deduced form the “total output” of the mitochondrial succinate dehydrogenase 
(also known as SQR or Complex II). As more cells will have a higher total 
turnover of ATP, “more cells” correlates with “more mitochondria”. Finally, 
since Complex II is a structural entity of mitochondria, it follows that “more 
mitochondria” will lead to “more Complex II”. A high total succinate 
dehydrogenase activity is thus indicative of cell proliferation and/or cell viability 
(more mitochondria and hence more cells in any case). 
 
A second concept used to insure cell viability is membrane integrity. Even truly 
apoptotic/necrotic cells might still have some viable enzymes and as such, 
these enzymes might apathetically go about reducing MTT (indicating the cell 
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is “viable”). But, since formazan is not cell membrane permeable, cells with 
intact membranes will accumulate formazan inside the cell.  On the other 
hand, cells with disrupted membrane integrity will spill their contents into the 
buffer along with the formed formazan (which will be decanted and thus will 
not contribute to the photometrical quantization). 
 
The validity of MTT assay can thus be judged on the combined grounds of 
how good these two “indicators” correlate with their respective variables 
(namely viability and total cell mass). Obviously, a cell with a compromised 
membrane will not be able to maintain any chemical gradients and will 
speedily descend towards thermodynamic equilibrium (i.e. homeostasis will be 
compromised). All things considered, a cell’s inability to accumulate formazan 
does indeed seem to be a good predictor of cell viability.  
 
The reduction of MTT as an indicator of cell proliferation is a complex matter. 
By measuring the total activity of a metabolic enzyme (i.e. complex II of the 
electron transport chain), the MTT assay immediately makes itself more 
identifiable as a metabolic assay rather than a viability assay. Thus, a more 
appropriate approach would be to state that the MTT assay associates with 
cellular metabolism. The counter case could be made that, since “metabolism” 
denotes the unique chemistry that we identify as “life”, metabolisms should 
causally follow the measured viability/proliferation index and should therefore 
be deduced from the MTT assay. 
 
Obviously, this is not necessarily the case. A high metabolism need not imply 
a large amount of life- it could also mean a low amount of life that just 
happens to be very busy (i.e. large numbers of highly active mitochondria). 
Conversely, a low metabolic turn over need not imply a low amount of cells, 
following the same logic (i.e. low numbers of mitochondria). Different cells 
have different metabolic outputs depending on their environment. Using a 
metabolic marker as an indicator of cell proliferation/viability is thus hazardous 
as it is neither necessary nor sufficient to indicate proliferation/viability. 
 
This being said, there is no reason to completely denounce the MTT assay 
per se. The assay seems reasonable as an indicator of cellular metabolism(s). 
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Of note though, complex II is not the only catalytic site at which the reduction 
of MTT to formazan takes place (Berridge and Tan 1993; Gonzalez and 
Tarloff 2001; Bernas and Dobrucki 2002) and the other sites do not 
necessarily correlate with mitochondrial activity, thus complicating the picture 
even further. 
 
The validity of the assay as a cell viability/proliferation indicator is not totally 
compromised as long as one remains wary of the parameters of the assay 
and how the experimental conditions impact upon these. Stress conditions 
that involve inhibition of cellular oxidative phosphorylation (e.g. hypoxia or 
starvation) might give false-negative results (or more formally, a type II error) 
and indicate cell death in cells which have  cells simply reverted to lower 
metabolic output as substrate is limited.  
 
4.1.2 Explaining the results 
4.1.2.1 Mitochondrial biogenesis? 
In light of the above, a different approach to the results is required. Instead of 
imagining cells proliferating at a enormous rate, it could be that the cell’s 
prokaryotic symbiot were busy propagating - more mitochondria would imply 
more mitochondrial protein, and by proxy, more succinate dehydrogenase. 
Interestingly, no study (to the best of my knowledge) exists that investigates 
the possibility of mitochondrial biogenesis induced by LLLT.  
 
Yet, by observing the literature, a causal link could be established: nitric oxide 
has been shown to induce mitochondrial biogenesis (Nisoli and Carruba 2006; 
Wadley and McConell 2007). In turn, LLLT have recently been shown to 
increase transcription of iNOS (Moriyama, Moriyama et al. 2005). Thus, LLLT 
can potentially increase mitochondrial biogenesis, via LLLT stimulated iNOS 
activity. 
 
 Alternatively, AMPK has also been shown to be activated by LLLT (Makela 
2006) which intern also plays a key role in mitochondrial biogenesis (Zong, 
Ren et al. 2002). In any case, these two potential pathways both represent 
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possible mechanisms by which LLLT could induce mitochondrial biogenesis. 
An increase in mitochondrial number would also be coherent with a prolonged 
24 hour effect. 
 
4.1.2.2  Increased succinate dehydrogenase? 
As mentioned, the reduction of the MTT-formazan is catalyzed (mostly, but not 
exclusively) by succinate-coenzyme Q reductase (succinate dehydrogenase, 
is in complex with other three subunits in the inner membrane of the 
mitochondria to form complex II of the electron transport chain). As an 
alternative, it could be that cells did not proliferate at all, but simply increased 
expression of the enzyme over time. This increased enzyme transcription 
would account for the fact that these results were observed 24 hour post 
irradiation.  
 
But what would be the benefit of increasing the expression of this enzyme? 
Investigating the metabolic position of succinate dehydrogenase presents two 
curious facts. Firstly, succinate dehydrogenase catalyses the oxidation of 
succinate, yielding fumarate and so doing also reduces flavin adenine 
dinucleotide (FAD) to FADH2 (which, by its reduction (gain of two electrons) is 
now an “energy transporting” molecule).  Secondly, the position of succinate 
dehydrogenase in the citric acid cycle is also possibly of significance. The 
fumarate product for succinate dehydrogenase is then enzymatically 
processed to malate  which in turn is catalyzed to oxaloacetate (Krebs and 
Johnson 1980).  Oxaloacetate is then “cycled” in the citric acid cycle and 
forms the very first substrate for Acetyl-CoA. Thus, besides supplying the cell 
directly with energy rich molecules (FADH2), succinate dehydrogenase could 
facilitate the flux of Acetyl-CoA through the citric acid cycle and thus also 
facilitate energy production. 
4.1.2.3   Increased electron flow through the ETC:  
  Cytochrome c involvement? 
It is also tempting to contemplate an increased flux through the electron 
transport chain. As mentioned, cytochrome c oxidase has been proposed to 
be the rate limiting step in the ETC (Karu, Pyatibrat et al. 2005). It is also 
proposed to be an active chromophore, the primary photon acceptor in photo-
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biostimulation. If the rate-limiting step is accelerated, it follows that the total 
flux in the system would increase. Though this implies an increase in 
metabolic rate, it would not necessarily describe the increased reduction of 
MTT (succinate dehydrogenase reduction of MTT is not dependant on how 
many electrons is passed on through the ETC). 
 
4.1.2.4   Analysis of antioxidant results: a possible indication of 
mitochondrial biogenesis? 
The partial increase in the MTT values of the antioxidant treated cells was a 
curious anomaly.  This could however be due to a sub-optimal concentration 
of antioxidant being used in the experiments.  The concentrations used were 
selected from previous experience using these compounds (Lacerda, Smith et 
al. 2006). 
 
This yet again brings into play another level of analysis on the results: 
Typically, the mitochondria are viewed as the cellular powerhouse. This 
however is not the whole story. Eukaryotic cells are in no way capable of 
“burning” (oxidising) our substrate (i.e. eukaryotes are not capable of 
performing oxidative phosphorylation). In fact, non-fermenting metabolites like 
fatty acids are totally and utterly useless to us, since they cannot be 
fermented. Our prokaryotic symbiotes (mitochondria) on the other hand are 
particularly fond of fatty acids and are well equipped for oxidative 
phosphorylation. 
 
The reason why eukaryotes never evolved the highly efficient mechanism of 
generating energy (oxidative phosphorylation is much more efficient than 
fermentation) is that we never had reason too: we had our prokaryotic 
symbiotes performing the task for us. Oxygen is incredibly toxic and indeed 
hazardous toward cellular machinery. That is why it is left totally and utterly, 
up to the mitochondria to perform oxidative phosphorylation. In a way, the 
mitochondria protect eukaryotes by acting as “oxygen vacuums”: the 
mitochondria capture and chemically process (burn) oxygen, releasing energy 
(e.g. ATP via continuation of a proton-motive-force) in the process. Thus, the 
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mitochondria not only produce ATP – they actively protect the cells from 
oxygen. 
 
As mentioned, it could be that LLLT causes mitochondrial biogenesis, with this 
increase in mitochondrial number protecting the cell from a hyper-oxygenated 
environment: with more mitochondria, their “oxygen vacuum capacity” would 
increase. This would explain why the LLLT group perform so much better than 
the non-irradiated group: the mitochondria protected the cells by chemically 
processing oxygen.  
 
Indeed, the control group probably lost cells as a result of oxidative stress. 
Whilst the MTT value of the irradiated group increased, the MTT value of the 
non irradiated groups could actually of decreased as a result of cellular death 
induced by oxidative stress.  
 
4.1.3 Summary: MTT 
In the end, a most probable interpretation involves an integration of some of 
the above mentioned mechanisms that would lead to an increase in MTT 
values. It is reasonable to expect that an increase in metabolism, either via 
mitochondrial biogenesis, increases in succinate dehydrogenase activity 
and/or increases in electron flux by augmenting cytochrome c oxidase activity 
would ultimately lead to an increase in the MTT value.  In turn, this could 
possibly stimulate cell proliferation. It is thus reasonable to expect at least 
some of the increased MTT value to be indeed attributed to cell proliferation.  
This could be confirmed in future studies by accurately counting cell numbers 
(both live and “dead”) and correlating this with the MTT value. This cell 
proliferation is also in line with the signalling molecules discussed (MAPK, Akt 
etc) which can be activated via ROS mediated mechanisms. In this regard, 
follow up studies investigating ROS formation (by example utilizing live cell 
imaging techniques (Alexandratou, Yova et al. 2005)) would be important in 
validating the antioxidant/ROS mechanisms involved.  
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Yet still, it seems highly unlikely that cell proliferation on its own could account 
for the observed MTT values, and the mitochondrial biogenesis hypothesis 
seem more likely. Future studies should look at employing more direct 
markers of cell proliferation (e.g. BrdU labelling) as opposed to mitochondrial 
proliferation (actually, the relationship between nuclear and mitochondrial 
DNA could also be investigated which might be more descriptive (Strand, 
Ingebretsen et al. 2008)) as well as possibly investigating mitochondrial 
metabolic activity (e.g. measuring membrane potential (Matsumoto-Ida, Akao 
et al. 2006)). 
 
4.2 ORAC ASSAY 
 
4.2.1 Cell ORAC results 
Though not significant, an interesting trend was observed with the irradiated 
cells, in that irradiation lowered the ORAC value obtained. As LLLT has been 
shown to induce ROS production (Karu, Pyatibrat et al. 1987; Callaghan, 
Riordan et al. 1996; Grossman, Schneid et al. 1998; Alexandratou, Yova et al. 
2002) it is tempting to speculate how laser induced ROS production could 
result in the observed decrease in cellular antioxidant status. This is, however 
speculative, especially given the variability in the results (which could be 
reduced by increasing the n).  
 
Nevertheless, the “rebound” effect seen at 15 minutes pos irradiation and the 
subsequent return to baseline levels does seem to indicate that something is 
happening within the irradiated cells.  It is possible that the rebound is as 
result of a normal cellular homeostatic response, in which the chemical 
endogenous antioxidant capacity of the cell is regenerated following depletion 
during and immediately after irradiation.  
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4.2.2 Blood plasma ORAC results 
Plasma ORAC levels of injured rats indicated a drop in antioxidant status for 
irradiated groups followed by a rise 24 hours post irradiation (Figure 3.9). 
Though it could be argued that LLLT decreased antioxidant status post 
irradiation, this seems unlikely (it requires validation which simply is not 
afforded by the literature). In any case, the results were insignificant. The 
injured group showed a decrease in antioxidant status 24 hours post injury. 
These result were, again, not significant, but would possibly be easier to 
explain, as neutrophils (activated in reaction to the inflammatory response in 
the injured tissue) might increase ROS production through the respiratory 
burst (Brickson, Ji et al. 2003). 
 
Rats injured and receiving treatment, as opposed to rats not receiving any 
treatment did not dramatically differ at either the 4 or 24 hour time points 
(Figure 3.10), although the treated groups demonstrated lower antioxidant 
status. This was not significant.  It may be possible, by increasing the number 
of animals studied, or by altering the dose to obtain significant differences.  
This was however, not possible during this study due to both financial and 
time constraints. 
4.2.3 Tissue  ORAC results 
Illustrated in Figure 3.11, samples were reasonably uniformly rated in terms of 
antioxidant status, with the exception of the 4 hour irradiated group (showing 
an increase in antioxidant status). With the exception of the 4 hour groups, all 
samples had a lower antioxidant status, which, in the context of an 
inflammatory response, can be explained in terms of the increased ROS 
production in the respiratory burst (Brickson, Ji et al. 2003). Despite these 
trends, no significant differences were observed.  As above this could be 
down to the low number of animals or inadequate penetration of the laser to 
reach the tissue.  This is currently under investigation in conjunction with the 
National Laser Centre. 
 
Interestingly, a trend is observed when comparing the injured groups to the 
laser treated groups (Figure 3.12.). The irradiated groups demonstrate an 
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increased antioxidant response over both 4 and 24 hours.  It has been shown 
that LLLT can increase antioxidant levels in skeletal muscle (Avni, Levkovitz et 
al. 2005). Though not significant, increasing sample size in future studies 
might provide significant results. 
 
Interpreting the results in a physiological context is extremely difficult, in that 
the difficulty does not lie with the lack of an explanation - it is in fact because 
of the overabundance thereof!  Many of the arguments produced to interpret 
the results are in fact synonymous with shooting an arrow into a wooden plank 
and painting the bull’s-eye around it. In the light of this sentiment, it is worth 
evaluating the assay and explaining some critical pitfalls and problems with 
the assay to cultivate a better understanding of the results. 
 
4.2.4 The ORAC assay 
The ORAC assay is a hydrogen atom transfer (HAT) assay that determines 
antioxidant capacity by measuring competitive reaction kinetics. It consists of 
3 basic components: a fluorescent probe, a radical donor and a fixed amount 
of antioxidant to compare the sample antioxidant capacity against (“a 
standard”). Basically, as the radical donor increases (i.e. the free radical 
concentration increases), the fixed amount of fluorescent agent present in the 
reaction mixture will progressively become quenched (by the radical species).  
Any antioxidant present in the system would scavenge the radicals, effectively 
“out competing” the fluorescent probe as substrate. This ultimately results in 
the extended viability of the fluorescent probe and would thus increase the 
total area under the curve (AUC) generated.  By measuring florescent 
intensities over time, a kinetic curved can be drawn from which the antioxidant 
capacity in any given sample can be deduced (from the total AUC).   
 
Since it conception is 1993 (Cao, Alessio et al. 1993) the ORAC assay has 
seen a number of modifications. A great leap in terms of both application and 
economic consideration was the replacement of β-phycoerythrin with 
fluorescein (FL) (Ou, Hampsch-Woodill et al. 2001). In the assay applied in 
our study, a fluorescein probe was adopted. Furthermore, 2'-azobis(2-
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aminodinopropane)-dihydrochloride (AAPH) was used as the radical (more 
specifically, H2O2) donor and 6-Hydroxy-2,5,7,8- tetramethylchroman-2-
carboxylic Acid (Trolox) was utilised as the antioxidant standard.  
 
 
 
Figure 4.1 Brief summary of the ORAC assay.  
(A) Photons emitted (494 nm) excite fluorescein 
molecule, resulting in the emission of a photon 
(521 nm) which is detected spectrometricly. This 
allow for the quantification of fluorescein 
molecules in sample.  
 
(B) In sample with a low antioxidant capacity, 
reactive species (notably hydrogen peroxide) 
degrade fluorescein resulting in a decrease 
emission of photons. This decrease in 
florescence over time is plotted on graph, 
generating in a kinetic curve. 
 
(C) A high antioxidant capacity results in the 
reactive species being quenched by 
antioxidant. This increase the half life of 
fluorescein in the system which in turn gives 
rise to a sustained florescent intensity. 
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The biological “antioxidant- arsenal” at an organism’s disposal can be divided 
as enzymatic and non-enzymatic. Enzymatic antioxidant elements include the 
selenocysteine containing glutathione peroxidase, catalase and members of 
the SOD family. Non-enzymatic antioxidants typically include “sacrificial 
scavengers” (such s vitamin C and E) as well as chemicals that prevent 
oxidative damage, but do not in themselves scavenge radical species. As an 
example of such a chemical, one can consider co-factors of enzymatic 
scavengers and chelating agents capable of removing transition metals which 
can form radical species via so called Fenton's reaction to be examples 
(Afanas'ev, Dorozhko et al. 1989; Lloyd, Hanna et al. 1997). It is also 
important to note that cells posses no enzymes to scavenge radicals such as 
singlet oxygen, hydroxyl radicals or peroxynitrite (Huang, Ou et al. 2005).  As 
a result the so called “sacrificial scavengers” have evolved.  
 
 
 
Figure 4.2 Representation of the relationship between cellular oxidizable substrate 
and molecules considered as antioxidants. Note, the diagram is only representative 
and not according to scale as this relationship will be tissue specific. Although the 
total oxidizable capacity of a cell is in general much larger than the population of 
antioxidants, antioxidants (by definition) have a much larger affinity towards reactive 
species and are thus able to protect cells from oxidative stress. 
 
110 
 
Obviously, not all the possible constituents of the broader term “antioxidant” 
are evaluated by a single assay such as ORAC. But, in regarding H2O2 as the 
major oxidant produced (Fleury, Mignotte et al. 2002), those antioxidants 
capable of its scavenging would give a biologically  relevant approximation of 
the antioxidant capacity of the tissue being analysed. Specifically in our study, 
the fact that not all antioxidants are water soluble also acts as a compounding 
factor in our analysis. Nevertheless, modifications to the ORAC assay does 
exist which allows for the quantification of lipophilic antioxidant capacity (Prior, 
Hoang et al. 2003). Thus, despite the lack of an absolute golden standard for 
antioxidant capacity determination, the ORAC assay has been shown in the 
literature to be a rather robust and trusted technique (Prior and Cao 1999).  
 
In the literature some authors use plasma while others prefer serum for 
measuring antioxidant capacity. In this regard, Ghiselli (Ghiselli, Serafini et al. 
2000) has pointed out that, during platelet aggregation (necessary for serum 
extraction) ROS is produced. Also, in the context of radical chemistry, 
antioxidants are easily oxidized by exposure to atmospheric oxygen and 
degraded by exposure to light.  In addition  both radicals and their scavengers 
are more liable to react with each other over time (if not frozen) (Ghiselli, 
Serafini et al. 2000). There are also growing concerns about inconsistent 
results possibly arising from experimental artefacts during the preparation of 
samples (Mayne 2003). In light of these concerns, the use of plasma, instead 
of serum, was decided upon.  
 
The ORAC assay has not only been used on serum/plasma, but it has also 
been successfully used to measure antioxidant capacity in mammalian tissue 
samples (Cao and Prior, 1999; Munkeby et al., 2004; Sofic et al., 2006), and 
with special reference in our contexts [muscle], (Kinnunen, Hyyppa et al. 
2005). In order to investigate any possible change induced by LLLT on the 
irradiated muscle, the ORAC assay was performed on samples of the 
gastrocnemius muscle. Since experimental rats were already to be sacrificed, 
it was decided to also extract blood via cardiac puncture during the biopsy 
procedure. This allowed another dimension of analysis by allowing us to 
evaluate “systemic” antioxidant capacity and so recognize possible anomalies 
in data as well as look for unexpected correlations.  
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Most of the molecules partaking in “radical-scavenging” reactions (and thus 
contributing to the AUC) are not considered antioxidants. In fact, it is by the 
very nature of the chemical reaction that takes place between reactive species 
and other metabolites, proteins, lipids etc. (which are potential oxidizable 
substrates) that reactive species are deemed hazardous to biological systems. 
In plasma, Cao et all found components not usually classified as antioxidants, 
such as ascorbate, glutathione, α-tocopherol and uric acid contribute to the 
major “scavengers” of reactive species in an ORAC assay (Cao, Alessio et al. 
1993). This unfortunately increases ORAC running time (the assay needs to 
run until completion to generate the AUC). Since reagents are, at least to 
some extent, heat liable or prone to photo-bleaching, and by reason of 
practical limitations on instrumentation and feasible time constraints, a 
balanced compromise between dilution and running time had to be made.  
 
In our ORAC protocol, the amount of runs, and therefore, by implication, the 
overall running time was much longer (180 min) then applied by most authors 
(35 min). To insure spontaneous photo bleaching does not compound results, 
a run in which AAPH substituted with PBS (thus, no radicals to quench the 
florescent probe) was included to observe “background” photobleaching. Over 
180 mins the fluorescent intensity decreased by about 3.7%. Though notable, 
this contribution is negligible if compared to the impact of AAPH on the rate of 
decay (which can deplete unprotected fluorescein by about 95% within about 
20 mins). 
 
 
 
Figure 4.3 Curve demonstrating background photobleaching over 180 minutes. 
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In order to prevent the runs being too long, samples can be diluted to reduce 
the antioxidant capacity. This was prohibited by the rationale behind our 
application of the assay: most authors in the literature were interested in 
antioxidant capacity per se, whilst, in this study, we were using the antioxidant 
status as a “derived instrument” to deduce a relative increase in reactive 
species following laser irradiation. This is a critical difference in our approach 
as to “classical” implementation of the ORAC assay: an immediate 10% 
increase in antioxidant capacity would lead to an immediate 10% increase in 
antioxidant capacity. But the inverse need not necessarily hold true: a 10% 
immediate increase in ROS production does not result in an immediate 10% 
decrees in antioxidant capacity. The reason for this is simply because much of 
the antioxidant capacity of a cell is enzymatic in nature and thus not linearly 
depletable (as would be the case if cellular antioxidant capacity were 100% 
based on “sacrificial’ antioxidants). 
 
In effect then dilutions were kept as low as possible to increase the “signal-to-
noise” ratio. If pronounced dilution schedules were to be followed the small 
change in antioxidant capacity could be diluted to such an extent as to be 
“lost” in experimental “noise” (the change in antioxidant status would be less 
than the background variance introduced by other factors).  By employing 
longer runs, dilution factors need not be as pronounced, which lead to an 
increase in the “experimental resolution” of the data generated. Having longer 
running times with less diluted sample aliquots was also a more favourable 
strategy from a purely practical point of view: less pipetting (in diluting 
samples) means less opportunity for potential experimental error to slip in.  
One other advantage of having longer runs in the assay relates to the fact that 
the ORAC assay was performed manually. As one pipettes into the wells 
across the plate (with a multi-channel pipette from top to bottom) there is a 
marginal time delay between the sample-wells at the top of the plate and the 
samples-wells at the bottom of the plate (roughly 20-30 seconds). This time 
delay is miniscule: 30 seconds on 180 min experiment equalling only a 0.28% 
deviation. One problem with this though is that the ORAC assay is a kinetic 
assay with the reaction demonstrating an exponential decay curve. Early in 
the reaction, the antioxidants/oxidizable-substrate are in abundance, 
promoting an increased reaction kinetic between the reactive species and any 
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antioxidants in the system (the reactive oxygen formation by AAPH is basically 
constant for the first couple of hours (Niki 1990)). Simply stated, the rate at 
which the antioxidants scavenge reactive species slows down over time.  
Thus the reaction will, by implication, take place at its fastest from the moment 
the reagents are added.  
 
This “time gradient” was also taken into account with “plate architecture” 
(when designating the allocated position of samples and standards to specific 
wells on the plate).  
 
 
 
Figure 4.4 Typical plate architecture. Only half the wells on a 96 well plate were 
used each run. Samples were loaded as to spread entire group (4 rats/Petri dishes in 
a group = 4 samples in group) according to a loading “time-gradient”. This way, the 
entire group has a representative sample (1-4 and 5-8) across the plate, promoting 
consistency. 
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As mentioned, the ORAC assay does not measure antioxidant capacity, but 
oxidizable capacity (which includes tissue constituents like proteins), and it is 
possible to extract proteins from the samples before performing an ORAC 
assay.  However, in this study, it was decided against doing this on the basis 
that treating samples increase their exposure to atmospheric oxygen which 
can oxidise samples and therefore influence accuracy. Instead, sample values 
were divided by their protein concentration (in order to normalise the values) 
and expressed as μmol Trolox per liter of sample per µg protein. 
 
This turned out to be an error, and, probably the major cause of the variability 
seen in the results. The effect of protein in samples on the ORAC results is 
not necessarily corrected for by simply dividing by it. Technically, the part of 
the ORAC value that originates from the protein’s oxidizable capacity should 
be subtracted from the total ORAC value. But since the relationship between 
protein concentration and sample oxidizable capacity is not known, it is not 
possible to do this.   
 
As mentioned in materials and methods section, PBS instead of RIPA buffer 
was used during the scraping of cells. Since RIPA buffer contains detergents 
which lyses cells, the use of RIPA buffer greatly assists in the detachment and 
harvesting of cells in culture.  The use of PBS led to the non-uniform scraping 
of samples which, we believe, ultimately resulted in the amplification of 
sample-to-sample variability in harvest fractions. Protein content would vary 
enormously, and, as such, dividing by the protein concentration skewed 
results even more. 
 
The reasons for not using RIPA buffer to harvest the cells were numerous, 
and included:  the chelating agents present in the buffer quench metal ions 
that might influence radical formation (notably copper and iron), which, 
through the Fenton reaction might form highly reactive radicals like the 
hydroxyl radical; compounds in the RIPA buffer are potentially highly 
oxidizable substrate for radicals - detergents such as Tween compounds 
(which are polysorbates) and NP-40 (nonyl phenoxylpolyethoxylethanol) are 
complex organic compounds with many molecular centres suitable for 
interactions with reactive species.  
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A major advantage of the ORAC assay is that is economical. Not only are the 
reagents inexpensive, but the instrumentation required is routinely available. 
Secondly, because of the simplicity of the assay (only 3 reagents), it has 
potential for automation.  Due to this the ORAC assay (along with the 
numerous modifications) has become the gold standard in the food and 
agricultural industry as an indicator of nutritional antioxidant capacity. 
 
But the assay does have some disadvantages. For one thing, the assay is not 
able to detect lipophilic antioxidants, and thus it ignores an important 
contributor to cellular antioxidant capacity. In addition the reagents used in the 
assay are extremely liable to environmental degradation, for example, 
fluorescein, like most fluorescent molecules, undergoes photo-bleaching on 
exposure to light, and the antioxidant standard, Trolox, is unstable and prone 
to oxidation.  Therefore slight changes in experimental conditions and the 
“reactivity” of the reagents used can contribute towards experiment to 
experiment variability.  
 
Some precautionary steps were taken and specific experimental “safeguards” 
were installed in the set up of the protocol to minimize experimental error. For 
one thing, reagents are relatively stable if stored properly (with the exception 
of the AAPH which has to be made up freshly for each experiment). In order to 
minimise variability stocks of the reagents were made, aliquotted and stored 
appropriately.  In addition each sample was run in triplicate and the results 
inspected in Excel by overlaying the fluorescein decay curve (for example see 
Figure 4.5). Curves of each triplicate batch were inspected in order to ensure 
accurate and consistent sample loading. Runs with deviating curves were 
omitted from data processing and repeated. 
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Figure 4.5 Representative of triplicate values of same sample overlaid. Graphs 
were visually inspected to insure sample loading was accurate. 
 
During the course of this study several pitfalls of the ORAC assay were 
highlighted. As a result it is the opinion of the researcher that the ORAC assay 
is neither sensitive enough nor accurate/consistent enough to be routinely 
employed in applications such as performed in this study.  
The ORAC assay, per se, is not criticised, rather, the application of the assay 
in our context is questioned.  For our application, other  alternative methods 
are available to allow measurement of both ROS production and oxidative 
stress in both systemic (Couillard et al., 2005; Kadiiska et al., 2005; Krieter et 
al., 2006; Stephens et al., 2006) as well as local (Alessio, 1993; Cherubini et 
al., 2005) settings. There are also live cell imaging techniques that allow the 
formation of radicals to be monitored real-time both in-vitro (Robinson et al., 
2006) and in-vivo (Flors, Fryer et al. 2006). 
 
It is thus the author’s opinion that no confident conclusion can be drawn from 
the ORAC results. Further studies should look at alternative markers (as 
mentioned). 
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4.3 Western blot  
As mentioned earlier, LLLT have been implicated in ROS production 
(Thannickal and Fanburg 2000; Hancock, Desikan et al. 2001; Pantano, 
Reynaert et al. 2006) and in turn, ROS have been found to modulate 
phosphorylation states of global cellular signaling components throug its 
effects on PTPs (Kamata, Shibukawa et al. 2000; Lee and Esselman 2002). 
Both AMPK (Figure 3.6.), being a key player in cellular energy homeostasis  
(Yamauchi, Kamon et al. 2002)  as well as Akt (Figure 3.5.) which 
demonstrate strong anti-apoptotic, signaling molecule as well as promoting 
protein synthesis (Bodine, Stitt et al. 2001) were shown to demonstrate an 
increase in activation (phosphorylated).  An increase in STAT 3 transcription 
(Figure 3.7) was observed 60 minutes post irradiation. STAT have been 
implicated in satellite cell activation/ proliferation and promoting cell survival  
(Kami and Senba 2002), making this molecule an appealing target for our 
investigation. 
 
 
4.4 Satellite cells staining  
As previously mentioned, there is enough evidence in the literature to support 
the use of CD34 (Beauchamp, Heslop et al. 2000; Hwang, Yuk et al. 2004; Shi 
and Garry 2006) and N-CAM (CD56) (Crameri, Langberg et al. 2004; Sinanan, 
Hunt et al. 2004; Olsen, Aagaard et al. 2006) as markers for satellite cells. It 
was decided to co-stain in order to maximize sensitivity and prevent false 
positive counting of non-satellite cells which also express these markers. 
 
As expected, injury did cause an increase in satellite cell activation, as 
illustrated in Figure 3.14. At each advancing time point, the number of satellite 
cells decreased, probably as a result of satellite cells differentiating as they 
started to fuse and form myotubes. 
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Laser irradiation itself seemed to have no effect on satellite cell number 
(Figure 3.15). It might be that laser irradiation acts in concert to the numerous 
growth factors/cytokines released during an inflammatory response (Smith, 
Kruger et al. 2008). Irradiation also seems to have little effect on injured rats as 
compared to untreated groups (Figure 3.16.). Again over time, a decrease in 
the number of satellite cells seen post injury was observed. 
 
One possibly interesting trend observe is that control groups (non-irradiated), 
demonstrate a sudden peak at 72 hours post injury in satellite cell number 
(see Figure 3.13 and 3.15). In contrast, irradiated cells do not demonstrate 
this sudden increase (see Figure 3.15). This could be interpreted in the 
context of a more advanced healing stage in laser treated groups, where a 
“second round” of satellite cell activation might not be necessary. But again, 
such conclusions remain to be pure speculative.  
4.4.1 Critical analysis of satellite cell 
  staining/counting procedure 
During microscopy a photo taken in any general field of view with a higher 
number of fast twitch fibers will have less myofibres visible due to their larger 
cross-sectional area than a muscle containing slow twitch fibres. In order to 
compensate for this, satellite cell numbers are normalized to fibre number. 
 
Another confounding factor in calculating satellite cell numbers in muscle is 
that satellite cells might not be equally distributed across fast and slow twitch 
muscle groups. It is generally accepted that satellite cells are more prevalent 
at capillaries (Schmalbruch and Hellhammer 1977) and at the site of motor 
neuron junctions (Wokke, Van den Oord et al. 1989). A recent study 
investigating the anatomical structure of satellite cell niches again affirmed the 
belief that satellite cells reside in close proximity to capillaries (Christov, 
Chretien et al. 2007).  As previously mentioned, slow twitch oxidative muscles 
are more highly vascularized then fast twitch muscles which imply that more 
satellite cells reside in this fibre type.  
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From a practical point of view, the asymmetric accumulation of satellite cells in 
slow twitch muscles could have an important physiological function: fast twitch 
muscle produce the majority of its energy by the metabolism of glucose. 
Under excessive contractile stress, these muscle ferment glucose, forming 
lactate. Interestingly, muscle is able to not only delay, but partially sidestep the 
so called “oxygen debt” accrued during high activity periods by shifting some 
of its respiratory burden to the liver. This “metabolic stunt” (known as the Cori 
cycle) is performed by exporting lactate into the circulation which is then, in 
the liver, converted back to into glucose via gluconeogenesis (which is ATP 
dependant, implying oxidative respiration). This glucose is released into 
circulation and can thus be re-utilized in glycolysis.  
 
It should be noted that the Cori cycle is not sustainable.  Anaerobic glycolysis 
has a total output of two ATP for each glucose, whilst glyconeogenesis require 
six ATP molecules to salvage one glucose molecule from lactate formed. 
Glycolysis and gluconeogenesis metabolically run in opposite directions, and 
as such, the simultaneous activation of this cycle in the body makes this cycle 
a “futile cycle” (but since to two processes takes place in different organs, it is 
still useful). Indeed, cancer cells also make use of this cycle, contributing to 
cachexia by metabolically “wasting” ATP (Tisdale 1997). 
 
Furthermore, the heart (which is principally driven by oxidative respiration) 
also takes up lactate and feed it into the Krebs cycle (thus utilizing circulating 
lactate for local oxidative phosphorylation)(Gertz, Wisneski et al. 1988). In a 
way, the resulting effect is as if “oxidative” glycolysis started in the skeletal 
muscle, but ended in the oxidative muscle of the heart. 
 
 In effect, the turnover of energy in fast twitch muscles is much higher than the 
amount of oxygen the muscle itself consumes. Since cellular respiration 
(oxidation in the mitochondria) is a major source of ROS, fast twitch fibres will 
not be subjected to such high levels of oxidative damage as slow twitch, 
oxidative fibres (which produce the bulk of their energy by local oxidative 
phosphorylation). Thus, the rate of myonuclei turnover is expected to be 
higher in oxidative than glycolytic muscle fibers. The increased number of 
local resident satellite cells in slow twitch muscle is therefore not only as a 
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result of increased capillary density but may also be as a result of the 
physiological requirement of the tissue itself.  
 
 
Figure 4.6 How skeletal muscle utilise a glycolytic energy generating strategy to 
delay (and partial circumvent) the oxygen debt. Note, the skeletal muscle exporting 
lactate have a dead weight loss of this energy rich molecule to the heart, but avoid a 
accumulation of local lactate. Also, the glucose supply via the Cori cycle is at a net 
loss to the body: every two moles of ATP generated in glycolysis require 6 mole of 
ATP as input to salvage glucose from lactate. But in doing so, the muscle is able to 
generate energy without any obligation to respiration.   
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In the light of the above, it might have been more effective to count the total 
number of myonuclei for comparison to satellite cell nuclei. As the rat 
gastrocnemius muscle is a muscle of mixed fiber type some samples would 
have had differences in the numbers of fast (glycolytic) and slow (oxidative) 
fibres in a field of view, thus complicating the determination and interpretation 
of satellite cell numbers. In addition at more advanced time points, satellite 
cells could have already contributed to the pool of myonuclei.  But since 
differentiating/differentiated cell nuclei would not be counted as satellite cells 
(by not expressing CD34 or CD56) this might also lead to the development of 
an incomplete picture of what was happening in the tissue. Having the total 
number of myonuclei per fibre might at the very least “flag” a general increase 
in myonuclei.  
 
Another drawback of this technique is that the spatial orientation and position 
of the satellite cell (relative to the basal lamina) cannot be utilized as an 
additional indicator of satellite cell identity, since the basal lamina can not be 
identified without immunostaining.  Also, since both markers stain cells in a 
particular part of the cell cycle, they might not identify other satellite cells 
which are more committed to differentiation or wich are totally quiescent. 
Nevertheless, considering there is not a true universal indicator for cell cycle 
specific identification of satellite cells (Montarras, Morgan et al. 2005), CD34 
and N-CAM could be considered to be reasonable markers. 
 
On that note though, another possible shortcoming with using the CD34/N-
CAM co-staining approach is the possibility that CD34/N-CAM might not be 
expressed together on all of the cells, thus leading to an under-counting of 
satellite cells.  
 
In future it will be possible to use desmin in conjunction with another satellite 
cell markers. Desmin stains the basal lamina and thus allows for the 
identification of satellite cells by their position relative to the basal lamina. 
Used in conjunction with another satellite marker, possibly Pax 7, Pax 3 or 
even N-CAM it may be possible to have a higher degree of confidence in 
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counting satellite cells in sections of muscle tissue (Halevy, Piestun et al. 
2004; Horst, Ustanina et al. 2006; Relaix, Montarras et al. 2006).  
 
Staining and subsequent counting of satellite cells it is a tedious and labour 
intensive task and this coupled to the limitations placed on markers one can 
use by the excitation and emission filters available on any give microscope 
means that one may want to develop alternative techniques for assessing 
satellite cell numbers in-vivo. 
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5. Chapter 5 
Concluding remarks 
 
The in-vitro results have revealed interesting trends and significant effects in 
response to laser irradiation. Though the assays used make elucidation of the 
exact characteristics of these response somewhat ambiguous, the observed 
results do indicate a positive physiological response to photo-biostimulation. 
Future studies should aim at identifying the responses in greater detail as well 
as elucidating the exact mechanisms invoked in these metabolic/cell-signaling 
systems. This is especially true for Western blotting studies where trends were 
observed, but no significant result observed. 
 
While the ORAC assay did show more variation between groups, the satellite 
cell counts between groups did not show much variation other than what one 
would have expected to be induced by the injury itself. It is thus possible that 
the ORAC results were merely artifacts of a procedure which inherently 
produces variable results. It could also be possible, in the in-vivo setting that 
laser did not penetrate the skin, or that the dose used was too low. The diode 
laser beam profile as well as the degree of tissue penetration of the laser light 
used in this study has not been categorized, either by ourselves or by anyone 
in the literature. Future studies should investigate the optical properties of both 
tissue as well as reagents/instruments used. As an example even media 
containing no phenol red would still have optical properties.  
 
In conclusion the results of this study suggest that whilst laser irradiation has 
effects that are easily discernable when using a single cell type in an in-vitro 
setting it is incredibly difficult to transfer these effects and results to an in-vivo 
setting.  Further work is required before conclusions can be made about the 
effectiveness of 638 nm laser irradiation on satellite cells in-vivo. 
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6. Chapter 6 
Addendum 
6.1 MTT  Colorimetric assay 
Reagents 
 Stock solvent  
1% isopropanol 
• Isopropanol: 99 ml 
• HAL: 1ml 
0.1% Triton 
• Triton-x: 0.1 ml 
• dH2O: 99.9 ml 
 
MTT assay Solvent (“50/51”) 
 
• 1% isopropanol: 50/51 
• 0.1% Triton: 1/51 
 
  1% MTT reagent 
 
• MTT: 0.01g 
• PBS:  1ml 
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NOTE: 
• Foil wrap container to avoid exposure to light 
• Keep on ice 
• Vortex solution 
• Filter (20µm) to get rid of excess MTT micro-clumps 
Method  
 
• Decant media (don’t wash) 
• Add to each Petri dish (slowly): 
o 1.5 ml PBS (preheated to 37 ºC) 
o 0.5 ml 1% MTT solution 
 
• Cover in tinfoil  
• Incubate for 2 hr in incubator 
 
 
• Cover in tin foil 
• Place on shaker for 5 min 
• Transfer content to “light-prove” (opaque) 2 ml tube 
• Centrifuge 2 min/1400 rpm 
o Hint: switch on spectrometer wills waiting for centrifuge 
• Decant supernatant into clean light prove 2 ml micro tube 
• Read absorbance at 540 nm: blank with Solvent (“50/51”) 
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6.2 Deparaffinization‐rehydration & 
  tissue permeabilization. 
 
Reagents 
• Xylene— Sigma-Aldric  
• Ethanol: 100%, 95%, 80% 50% 
• 0.1% Trypsin 
Method 
 
Hint: carefully plan possible staggering steps! Prepare 10 Coplin jars in series 
filed 2/3 with the above mentioned reagents, according to following schedule 
for each sample incubation step: 
 
1)      Xylene (5 min)   6)      95% ethanol (3 min) 
2)      Xylene (5 min)   7)      80% ethanol (3 min) 
3)      100% ethanol (3 min)  8)      50% ethanol (3 min) 
4)      100% ethanol (3 min)  9)      dH2O (3 min) 
5)      95% ethanol (3 min)  10)    dH2O (3 min)  
 
• Pre-warmed Coplin jars filled 2/3 with 0.1% Trypsin in water baht at 37ºC. 
• Place slide in preheated 0.1% Trypsin and incubate 20 min.  
• Immediately proceed with immunohistochemistry after deparaffinization-
rehydration.  
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Make sure Trypsin is 37ºC (don’t measure the temperature of the water bath- 
though the water might be 37ºC, the Trypsin might still be cold). Remove 
thermometer and place processed slide into trypsin bath. Incubate for 20 min.  
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6.3 Haematoxylin and eosin 
  progressive staining 
Reagents 
• Ethanol: 100%, 95%, 70% 
• Xylene 
• “10% Acetic alcohol” (named by convention not actual concentration) 
o (10 ml 1% HCl in 1ℓ 70 % ethanol) 
• Eosin 
o Stock: 10 g Eosin dissolved into 1ℓ dH2O 
o Working solution 
? Prepare fresh: 10 ml Eosin stock in 90 ml dH2O. Filter solution. 
? Add 2~3 drops glacial acetic acid in to 100 ml work-solution 
• Mayer's Haematoxylin 
 
Add the following reagents to 1ℓ dH2O  
o aluminium potassium  50g 
o dissolve in dH2O 
o 5 g Haematoxylin powder 
o dissolve in dH2O 
o 0.4g sodium iodate 
o 20ml glacial acetic acid 
 
? Heat solution up to boiling point. Remove from heat and rapidly cool down 
in fridge 
? Add 4 ml glacial acetic acid to 100 ml Haematoxylin solution before 
staining. Filter before use 
 
• Scott’s tap water 
o Dissolve 3.5 g NaHCO3 in tap water 
o Add 20 mg MgSO4 
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o Add 10 ml 37% formalin 
 
Method 
Prepare 21 Coplin jars in series flied 2/3 with the above mentioned reagents, 
according to following schedule for each sample incubation step: 
 
1) Xylene (10 min) 
2) 100% ethanol (10 dips) 
3) 100% ethanol (10 dips) 
4) 95% ethanol (10 dips) 
5) 95% ethanol (10 dips) 
6) 70% ethanol (10 dips) 
7) dH2O (10 dips) 
8) Haematoxylin (10 min) 
9) dH2O (10 dips) 
10)  Acetic alcohol (10 dips) 
11) dH2O (10 dips) 
12) Scott’s tap water (10 dips) 
13) dH2O (10 dips) 
14) Eosin (2 min) 
15) dH2O (10 dips) 
16) 70% ethanol (10 dips) 
17) 95% ethanol (10 dips) 
18) 95% ethanol (10 dips) 
19) 100% ethanol (10 dips) 
20) 100% ethanol (10 dips) 
21) Xylene (10 dips) 
 
Gently tap of execs xylene and mount sample wit mounting media and 
coverslip. 
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6.4 Automatic tissue processing 
 
Reagents 
Paraffin wax (Histosec, Merk) 
Xylene (Sigma-Aldric) ~2ℓ 
Ethanol: 100%, 95%, 90% 70% (2.5, 1.5, 0.8 and1.5 ℓ respectively) 
Method 
Tissue sample previously soaked in formaldehyde need to be: (a) dehydrated, 
(b) “cleared” or be saturated with a medium which accommodate (c) 
impregnation with paraffin. 
  
After preparing reagents, pour ~700 ml of each reagent into glass flask on 
tissue processor in the order (as indicated below). Tissue processor should be 
pre-programmed according to following time-schedule per sample incubation 
step: 
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6.5 Immunohistochemical staining: 
  double‐labelled probing  
Notation 
 
Suppliers of antibodies 
 
Monoclonal mouse anti-human CD34 (ICO 115) —sc-7324, Santa Cruz 
Polyclonal rabbit anti-human NCAM (H-94) — sc-8305, Santa Cruz 
Donkey serum, donkey anti-rabbit, donkey anti-mouse — Jackson 
immunoresearch Inc. 
Reagents 
Method  
All volumes added to slide is 40 µl  
 
• After completing deparaffinization protocol 
• Gently flick of excess PBS before encircling with wax pen 
• Block for 20 min in serum at room temperature 
o NOTE: Use serum from same animal in which 2º antibodies was raised! 
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• Flick of excess serum 
• Incubate section with 1st1º antibody for 4hr at room temperature:  
o Rabbit anti-N-CAM (1:100 dilution)  
• Rinse slide in PBS 
• Incubate section with 1st2º antibody for 40 min at room temperature 
o Donkey anti-rabbit--Texas Red conjugated (1:1000 dilution)  
• Incubate over night at 4ºC 
• Rinse slide in PBS 
• Incubate section with 2nd1º antibody for 40 min at room temperature 
o Mouse anti-CD34 (1:100 dilution) 
• Rinse slide in PBS 
• Incubate section with 2nd2º antibody for 30 min at room temperature  
o Donkey anti-mouse--FITC conjugated (1:1000 dilution)  
• After 15 min, add Hoechst (1:500) on slide (wile incubating 2nd2º antibody) 
• Rinse slide in PBS 
• Mount cover slide with DAKO™ fluorescent mounting media 
 
Useful hints  
 
? Be extremely careful to avoid cross-recognition of the antigens when 
selecting antibodies. Also make sure not to mix-up species serum/antibodies 
combinations. Also, if possible, pick your secondary antibody to be from the 
same specie. This will ease serum-blocking step.  
? Flick of excess PBS as this will dilute reagents and give rise to inconstant 
staining between samples. 
? Calculate antibody volume carefully- antibodies are expensive! About 40 µl 
per section should be sufficient. Apply following formula for final volume: 
 
(# Sections × # Slides) × 40 µl = final volume antibody (µl) (add extra 40 µl to 
final volume) 
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6.6 The ORAC Assay Protocol 
Reagents 
TROLOX: Vitamin E analogue with potent antioxidant properties. Water 
soluble (up to 0.5 mg/ml) and cell membrane permeable. 
Fluorescein: Fluorescing agent with an absorption maximum at 494 nm and 
emission maximum of 521 nm (in water). Susceptible to degradation by 
reactive species. 
AAPH: An azo-initiator producing peroxyl free radical (which degrade 
fluorescein). 
Phosphate buffer: Buffered at pH 7.4 
Stock solutions 
6.6.1.1   Phosphate buffer 
• 6.5g K2HPO4 in 500ml H2O (1) 
• 5.1g KH2PO4 in 500ml H2O (2) 
• 300 ML (1: K2HPO4) in 1  beaker 
• Add (2: KH2PO4) until pH 7.4 
Trolox  
Trolox is made up in a two-step dilution 
Trolox pre-stock (9.988mM) 
• Place 15 ml Falcon tube (wrapped in tin foil) on scale 
• Zero scale 
• 0.025 g Trolox into tube 
• Expose volume indicators and fill up to 10 ml with ice cold phosphate buffer 
by slowly pipetting 
• Gently mix by inverted pipetting gently (avoid rigorous shaking, as this 
expose the Trolox to O2 which will readily oxidize the Trolox) 
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Trolox (400μM Stock) 
• Add 21.12 ml Phosphate buffer (cold) into 25 ml brown glass vial 
• Add 0.88 ml pre-Stock (9.988mM)  
• Gently mix by inverted pipetting gently  
• Aliquot 250 µl into 40 pre-marked tubes 
• Freeze down in -20 or -80 ○C depending on estimate time of storage 
 
Only 0.88 ml of the pre-stock was used. If desired, more aliquots of stocks can 
be made. 
 
  Fluorescein (5 ×10-3 mM stock) 
 
• Place 25 ml glass vial on scale 
• Place 2 ml light prove tube into the vial as to have the tube rested on lip of 
the  vial cap-screw   
• Zero scale 
• Add 1.5 mg fluorescein  
• Full up with 1.5 ml phosphate buffer 
• Gently mix by inverted pipetting 
• Pour 50 ml phosphate buffer into light prove vial  
• Aliquot 94.33 μl in the vial containing 50 ml phosphate buffer 
• Store: 4 °C, keep in dark to avoid photobleaching 
Working solutions 
  Fluorescein (8.16 ×10­5 mM working solution) 
• Pour 19.7 ml phosphate buffer into flask wrapped in tin foil 
• Add 326 μl Stock in 19.7 ml phosphate buffer 
• Keep on ice 
 
  AAPH (153 mM) 
• Add 414 g into 10 ml phosphate buffer 
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• Keep on ice, make fresh  
Trolox (working solution): standard curve  
Make a dilation range as follow: 
• Place 200 μl PB in  5 tubes (each) pre-labelled 200, 100, 50, 25, 12.5 
• Add 200  μl Trolox stock (400μM) into tube-1 and mix by gently invert 
pipetting 
• Add 200  μl of tube-1 (thus, 100 μM) into tube-2 and mix by gently invert 
pipetting 
• Repeat procedure for tube-3 and tube-4 
Preparing samples and reagents 
• If phosphate buffer were not stored in fridge, place in fridge to allow 
phosphate to  cool down to ~4 ○C 
NOTE: AAPH donate H2O2 by thermal decay- something to be postpone until 
the initiation of the assay in plate reader! Keep cold at all time. 
• Containers in which AAPH and fluorescein are to be made up in flask pre-
 wrapped in tin foil. 
• Defrost Plasma/cells on ice (tissue sample should be ORACE immediately 
after sonication). 
• Defrost Trolox stock solution on ice 
While samples are defrosting: 
o Mark micro tubes in which samples are to be diluted: each sample is done 
in triplicate, thus, 3-tubes/sample 
o Mark tubes for Trolox dilution curve 
o Prepare multi-pipettes: p-200 set at 150 µl :::  p-100 set at 25 µl 
o Switch on plate reader, insert black plate and select run-protocol 
 
• Make up Trolox working solution (as explained) 
• Dilute plasma (×75) or tissue (× 200) in phosphate buffer (not in RIPA 
buffer!) 
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Executing assay 
• Before commencing with the assay, decant fluorescein and AAPH into 
separate marked crypts which will accommodate multi-pipetting. 
 
• Using a p-100 pipette: 
 
o Pipette 25 μl PB into wells designated as blanks  
o Pipette 25 μl Trolox into wells designated for standard curve 
o Pipette 25 μl sample into designated well 
 
• Using a p-200 multi-pipette, add150 μl fluorescein working solution (8.16 
×10-5 mM) into every well 
• Incubate plate in plate reader for 10 minutes at 37 ºC (very important!) 
• Using a p-100 multi-pipette, add 25 μl AAPH (153 mM) into every well  
• The reaction commence when the cold AAPH added to the warmed up 
reaction media- work speedily! 
Analysing results 
Data can be exported into Excel format. These results should be cut and 
passed into a pre-programmed Excel spreadsheet to calculate the AUC. Using 
values obtained for each Trolox dilution (Seen diagram on following page).  
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6.7 Bradford: protein quantification 
 
The Bradford method is a cheap, quick and easy method for quantifying 
protein content in samples. It is sensitive down to the down to 20 µg/ml range 
and are less liable to interference by other non-protein compounds (with the 
noteworthy exception of SDS). The method relies on the binding of 
Coomassie Brilliant Blue to protein, more specifically, basic amino acids like 
lysine and arginine. This makes the assay a relative one as the binding varies 
with protein amino acid sequence. 
 
Unbound under acidic conditions, the dye has an absorbance maximum at 
470 nm and 650 nm (given rise to a red/pink-brown colour). When bound, the 
dye’s absorbance maximum shift towards 595 nm (bluish colour). A standard 
curve is generated by measuring the absorbance of control samples over a 
known dilution range. By measuring the absorbance spectrum of an unknown 
sample and comparing it to the absorbance on the standard curve, the protein 
concentration of an unknown sample can be deduced.  
Bradford reagent Stock (6 X) 
 
• 500 mg Coomassie Brilliant Blue in 250 ml 95% EtOH 
• 500 ml Phosphoric acid (add under a fume hood) 
• Full up to 1L with dH2O 
• Store at 4 ○C 
 
Bradford working solution 
• Dilute with dH2O in 1:5 ration 
• Filter using 2 filter papers dubbed folded.  
• Filter procedure might need to be repeated until solution is light brown in 
colour 
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Bradford protocol 
6.7.1.1 Standard curve 
• BSA stocks (1 mg/ml) must be thawed at room temperature. Keep on ice 
Hint: mark 7 Eppendorf tube tubes for standard curve as well as tubes for 
samples will BSA thaw 
• Dilute with dH2O in 1:5 ration for a working solution (200 µg/ml). 
• Aliquot samples into marked tubes according to following schedule table: 
BSA Standard Curve 
 
 
 NOTE: Tube without any BSA (bottom of table) will be used as blank 
 
• Vortex each tube 
• Let samples stand at room temperature for about 5 min  
o Hint: spectrophotometer can be started up in the mean time  
o Take reading within one hour after mixing sample with reagent 
• Aliquot into appropriate covet, zero with blank, read absorbance at 595 nm 
• Use Excel to plot a linier standard curve 
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Samples  
Prepare samples and standard together to avoid variation on results 
• 900 µl Bradford Reagents 
• 95 µl dH2O 
• 5 µl Protein sample  
• Vortex each tube 
• Let samples stand at room temperature for about 5 min  
• Aliquot into appropriate covet, zero with blank, read absorbance at 595 nm 
 
Note: 
If sample concentrations are too high (above highest value in your standard 
curve), samples can be dilute with RIPA buffer. 
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6.8 Western‐blot Analysis 
Casting gel 
 
• Clean cover plates with methanol 
• Place glass slides back-to-back and clamp securely 
• Place clamped plates in stand and add water (check for leakage).  
 
 
Executing Electrotransfer (semi-dry system)  
Buffers for Electrotransfer system 
Anode buffer 1 
• 0.3 M Tris-base pH 10.4 
• 20 % methanol 
 
Anode buffer 2 
• 25 mM Tris-base pH 10.4 
• 20 % methanol 
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Cathode buffer 
• 25 mM Tris-base 
• 40 mM ε-aminohexanoic acid 
• pH 9.4 
• Full up with methanol until 20 % of total volume 
 
Preparation 
 
For each gel, gut 8 Whatman 3MM papers and one PVDF membrane to 
required size: the Whatman slightly smaller than the gel itself, the PVDF 
membrane slightly smaller than the Whatman paper. Handle the membrane 
with tweezers. Make sure the transfer apparatus is clean and clear of any 
debris. 
 
• Soak 3 Whatman papers in anode 1 buffer 
• Soak 1 Whatman papers in anode 2 buffer 
• Soak 4 Whatman papers in cathode buffer 
• On the plate of the semi-dry apparatus, place 3 Whatman papers soaked in 
anode 1 buffer. 
• Wet a glass tube in anode buffer 1 and gently role over Whatman papers to 
remove any bubbles 
• Soak Whatman papers in methanol for about 15 seconds, moving it gently to 
remove air bubbles 
• Place PVDF membrane on Whatman papers 
• Wet a glass tube with methanol and gently role over PVDF membrane to 
remove any bubbles 
• Take gel with proteins of interest and wet in anode buffer 2: this can be done 
when removing the gel from the back plate by gently swirling the gel attached 
to the plate in anode buffer 2 until it fold of. 
• Wet a glass tube in anode buffer 2 and gently role over gels to remove any 
bubbles 
• Place 4 Whatman papers soaked in cathode buffer on top of gel 
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• Wet a glass tube in cathode buffer and gently role over Whatman papers to 
remove any bubbles 
• Gently wet apparatus plates and clad semi-dry 
• Close lid, making sure the electrodes are secure in position. Run for 1 hour at 
0.5 A current at 15 V 
• After electrophoresis, gently lift lid and remove Whatman papers 
• Fix protein to membrane by placing the membrane in 100% methanol for few 
seconds (long enough to soak the membrane).  
 
Immunoprobing of protein:  Akt, Akt­p, AMPK, AMPK­p, 
STAT­3 and β­actin. 
 
Blocking 
• Prepare Tris Bufferd Saline-Tween 20 (TBS-T, 0.05%) 
• Use TBS-T20 as solvent: add Elite© non-fat milk to final concentration of 
5% (w/v) 
• Incubate for at least 2 hours room temperature (preferably over night at 
4ºC). 
 
Probing: primary antibody 
• Wash membrane in TBS-T thoroughly: 5 washes, 5 minutes each on the 
“belly-dancer”. 
• Prepare a 1:1000 dilution of antibody in TBS-T (5µl 1˚ antibody in 5 ml TBS-
T) 
• Incubating with primary antibodies (diluted in TBS-T) overnight at 4 ˚C. 
 
Probing: secondary antibody 
• Wash membrane in TBS-T thoroughly: 5 washes, 5 minutes each on “belly-
dancer”. 
• Prepare a 1:1000 dilution of antibody in TBS-T (5µl 2˚ antibody: 5 ml TBS-
T) 
• Incubate 1 hour at room temperature 
• Wash membrane in TBS-T thoroughly: 5 washes, 5 minutes each on “belly-
dancer”. 
144 
 
• Add 0.5 ml ECL (enhanced chemiluminescence kit Amersham Bioscience, 
UK limited) reagent 1 and 2 (each 0.05 ml) to membrane. Ensure reagent is 
evenly distributed across membrane. Washing membrane with ECL (by gently 
revolving container) for one minute at room temperature. 
• Transfer membrane to plastic membrane protector 
• Place protected membrane in film cassette with protein side facing up 
 
• Expose membranes on Hyperfilm (Hyperfilm, Amersham Bioscience, UK 
limited) in dark room for ± 5 minutes 
• Place in developer for about 30 seconds.  
• Wash and fix film 
• Quantified by densitometry with UN-SCAN-IT© PROGRAM (Silk Scientific 
corporation, Utah, USA). 
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6.9 RIPA buffer 
 
The buffer constituents can be divided between “stable” and “unstable” 
constitutes: it is advise to first proceed adding the “stable” reagents before 
proceeding with the application of the liable reagents (specifically, protein 
inhibitors). Some of the reagents are light sensitive- cover beaker (in which  
50 mM Tris is to be made up) in tin foil.  
 
Also, if phosphatase assays are to be done, phosphatase inhibitors should be 
avoided in RIPA buffer (e.g Na3VO4 and NaF). Similarly some of the ionic 
detergents denature some proteins which might result in a decrease in 
activity. Many companies sell kits and buffers tailored for specific assays and 
might be consider. 
 
Bearing in mind the amount of reagents required in preparation of RIPA buffer, 
it is useful to first familiarize oneself with the precise location of the reagents in 
the lab. Also, give thought to how the RIPA buffer is to be used as this has 
implication for volume to be aliquot per stored units (eg. 15 ml falcon tube, or 
1.5 ml Eppendorf tube).  
 
Final concentrations  
• Tris-HCl: 50 mM 
• Na-deoxycholate: 0.25% 
• EDTA: 1mM 
• PMSF: mM 
• Leupeptin: 1µg/ml 
• SBT1: 4µg/ml 
• Benzamidine: 1mM 
• Na3VO4: 1mM 
• NaF: 1mM 
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Overview of reagents  
NaF: (Sodium fluoride): Preserve the protein phosphorylation state in proteins 
by inhibiting phosphoseryl and phosphothreonyl phosphatases (PSPs) TOXIC 
(can cause fluoride poisoning). 
 
Na3VO4: (Sodium orthovanadate) Inhibit phosphatases and ATPasas 
 
Na-deoxycholate: a biological detergent that lyses cells and solubilise cellular 
membrane components. 
 
EDTA: Chelating agent that can sequester di- and trivalent metal ions Mn(II), 
Cu(II), Fe(III), Co(III) 
 
PMSF: (phenylmethanesulphonylfluoride) : block serine proteases (e.g trypsin 
and chymotrypsin). Short t1/2 (+/- 40 min).Toxic! 
 
Leupeptin: inhibitor of protease, including calpain. 
 
SBT1: (Soybean trypsin inhibitor): inhibits trypsin and some enzymes with 
simile protease mechanisms. 
 
Benzamidine: Reversibly inhibit trypsin/ trypsin-like enzymes as well as 
serine proteases in a competitive manner. 
 
Triton X-100: Non-ionic surfactant. Solubilise membrane proteins, cause 
membrane permeability  
 
NP-40: Tergitol-type NP-40. Detergent 
 
The following guideline is for 100 ml RIPA buffer at final concentration as 
mentioned. Stock solutions of some reagents were made up in advance (stock 
concentrations is mentioned were applicable.)  
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Constituents   
1) 50 mm Tris-HCl 
• 790 mg Tris + 900mg Cl + 75 ml dH2O 
• Solution is alkaline: Calibrate pH Meter range.  pH 7.4 using diluted HCl 
2) 10 ml 10% NP-40 
3) Na-deoxycholate: 0.25% 
4) 1 ml 100mM EDTA pH7.4 
5) 50 µl PMSF 200 mM 
6) 100 µl leupeptin 1mg/ml 
7) 80 µl SBT1 5mg/ml 
8) 100 µl Benzamidine 1M 
9) 1 ml Triton X-100. (Very viscous- gently warming up before helps with 
pipetting!) 
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6.10 PBS buffer 
 
• 800 ml dH2O 
• 0.2 g KCl 
• 8 g NaCl 
• 1.44 g Na2HPO4 
• 0.24 g KH2PO4 
• Adjust pH to 7.4 with HCl.  
• Fill up with H2O to 1ℓ 
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